Abstract
Plant-derived products and their extracted compounds have been used in folk medicine since early times. Zimbro or common juniper (Juniperus communis) is traditionally used to treat renal suppression, acute and chronic cystitis, bladder catarrh, albuminuria, leucorrhea, and amenorrhea. These uses are mainly attributed to its bioactive composition, which is very rich in phenolics, terpenoids, organic acids, alkaloids, and volatile compounds. In the last few years, several studies have analyzed the huge potential of this evergreen shrub, describing a wide range of activities with relevance in different biomedical discipline areas, namely antimicrobial potential against human pathogens and foodborne microorganisms, notorious antioxidant and anti-inflammatory activities, antidiabetic, antihypercholesterolemic and antihyperlipidemic effects, and neuroprotective action, as well as antiproliferative ability against cancer cells and the ability to activate inductive hepato-, renal- and gastroprotective mechanisms. Owing to these promising activities, extracts and bioactive compounds of juniper could be useful for the development of new pharmacological applications in the treatment of several acute and chronic human diseases.
Keywords: bioactive compounds, phenolic compounds, essential oils, biological potential, in vitro studies, in vivo studies, Juniperus communis L.
1. Introduction
Natural products have an important role in the research and development of new drugs. People have always extracted natural products from several natural sources, such as marine organisms, microorganisms, animals, and medicinal plants [1]. The main extracts from natural products come from medicinal plants. Plant-derived products and compounds have been used worldwide since ancient times in folk medicine as remedies for several diseases, such as tinctures, teas, poultices, maintaining high prevalence in public health [1,2,3,4]. Advances in clinical research and quality control have shown a greater value of herbal medicine in the treatment and overcoming of many diseases. Recent works report promising potential regarding the use of plants in the treatment and/or prevention of several hard-to-cure diseases, such as atherosclerosis [5,6], cancer [1,2,3,7,8], cardiovascular diseases [9,10,11,12], diabetes [8,13,14], and neurological disorders [4,15,16], among others.
The genus Juniperus includes roughly 68 species and 36 varieties and belongs to the Cupressaceae family [17]. The plant Juniperus communis L., named “zimbro” in Portugal, is a shrub or small evergreen tree; a perennial and long-lived coniferous, woody pioneer and colonizing plant, adapted to low nutrient availability in soil and having one the widest distribution ranges among the different plant species [18]. Its population is spread globally, being the only Juniperus species found in both hemispheres, with reports of this plant in Arctic regions of Asia and North America. In Europe, the largest population is found in some parts of the Alps, Scandinavia, Poland, northwest European lowlands, and Mediterranean mountain regions [19,20]. A significant population of “zimbro” is found in the Natural Park of Serra da Estrela, Portugal, where the var. alpina is mainly found at higher altitudes and the var. hemisphaerica at lower altitudes [21]. The wide geographical distribution is the principal reason for the remarkable variation in the morphological characteristics and secondary metabolites’ chemical composition [17].
J. communis has been used traditionally in folk medicine for renal suppression, acute and chronic cystitis, catarrh of the bladder, albuminuria, leucorrhea, and amenorrhea [22]. Indeed, this plant presents carminative, diuretic, emmenagogue, digestive, anti-inflammatory [23,24,25], antifungal [26,27], antibacterial [26,28], analgesic [29], hepatoprotective [30], antidiabetic and antihyperlipidemic [31], antioxidant [32], antihypercholesterolemic [33], and anticataleptic effects, and the ability to act as a neuroprotective agent against Parkinson’s disease [19,22,34]. Particularly, their berries can be used as antiseptic, stimulant, and styptic agents, and in the treatment of migraine, infantile tuberculosis, rheumatic arthritis, gout and painful swellings, chronic Bright’s disease, piles, and nephrotic dropsy in children [19]. Additionally, it is known that Native Americans used berries as a female contraceptive, anorexigenic agent, and in the treatment of diabetes [35]. Their essential oils are aromatic, possessing a light fruity fragrance which is considered psychologically uplifting [35]. Concerning their dried berries, they are largely used to flavor meat, soups, sauces, stews, stuffing, pickled foods, gin, liquors, bitters, Swedish beer, and borovička (a Slovak national alcoholic beverage similar to gin), being firstly crushed or grounded to release their flavor before being added to dishes [17,35].
On the other hand, J. communis seeds are too bitter due to their astringency. They are rarely consumed raw, usually being dried for use as a culinary component in different parts of the world. Together with juniper berries, they are commonly burnt in temples during religious ceremonies to purify the ambient air [36].
Relatively to their composition, “zimbro” plant parts are mostly composed of sugars, resins, organic acids, alkaloids, terpenic acids, leucoanthocyanins and flavonoids, gums, lignins, and wax. Their aromatic oils are rich in hydrocarbons of monoterpenes (α-pinene, β-pinene, sabinene, and myrcene), diterpenes, and sesquiterpenes [17,19,23,32,35,37]. All of them contribute to the health-promoting properties shown by this plant [34,38,39,40].
This review will outline the experimental technical progress of broad interest in J. communis vegetal part’s phytochemical composition and their importance in the treatment of diseases, summarizing the main effects of their active natural compounds in medical therapy.
2. Scientific Classification
J. communis species belongs to the Pinopsida class, Pinophyta division, Pinales order, Cupressaceae family, and Juniperus genus. Its binominal name is J. communis L.
The Juniperus genus is one of the most diverse within the conifers, being placed in the Cupressaceae family and including more than 60 species. It presents cosmopolitan distribution with a great capacity to develop in xerophytic and salinity conditions, although it is easier to find them in high-rainfall regions [41,42]. They are dioecious trees, producing seeds every 2 or 3 years that may have a globose or spherical morphology and be dispersed by zoocoria (e.g., frugivorous birds and small mammals), which allows them to colonize new territories quickly. In addition, they can be differentiated taxonomically into three well-differentiated sections, which represent different degrees of evolution within the genus, according to genetic analyses [41,43]. The Caryocedrus section, which is considered the most ancestral from an evolutionary point of view, is limited to areas of the Peloponnese, Anatolia, and Asia Minor and is only represented by the species J. drupacea, with acicular leaves, an anchor point to the stem, and woody cones [44]. The Juniperus (=Oxycedrus) section has a Holarctic distribution reaching the Mediterranean; it is represented by 14 species with acicular leaves, an anchoring point to the stem, and resiniferous cones. The third section, the Sabina section, is mainly found in the northern hemisphere and mountainous areas of the African continent. However, it also has some type of resin, and is distinguished from the other ones since it has decurrent needle-like or scale-shaped leaves and juicy cones [45]. According to these characteristics and with the fossil record, it is thought that the diffusion point of this genus occurred in the eastern Mediterranean region, first colonizing the northern regions of the Eurasian continent, and from there passing to the American continent at least 25 My ago [43].
All juniper species stand out for their high content of essential oils and phenolic compounds and are largely included in the traditional medicine of different cultures throughout the planet, exhibiting a wide range of biological activities and industrial applications [46]. Among them, it is worth highlighting the “zimbro” (J. communis) plant, since it shows the widest distribution, being practically circumboreal [43,47]. Another remarkable characteristic of this species is the ecological plasticity supported by great genetic variability, which translates into a substantially high number of varieties with phenotypes ranging from medium-sized trees (3–4 m high) to small creeping shrubs (Figure 1) [41,43]. The populations of the Iberian Peninsula are very diverse, and due to their position, their distribution is relegated to mountainous and more humid areas with a territorial occupation in islands, thus scaping from the thermophilic and xeric character of the nonmountainous lands of the Peninsula [44,47]. Indeed, it is believed that many years ago, this territory acted as a glacial refuge for many varieties that are currently found further north; even so, the populations of var. hemisphaerica show a high degree of genetic uniqueness, while the var. alpina (also known as var. nana) is mainly distributed in the upper areas of the mountains of the Iberian Peninsula, such as the Serra da Estrela mountains. These mountains are located in the middle interior of mainland Portugal and display an oromediterranean climatic island, being an isolated population from other populations of the Central System mountains or Cantabric System mountains [21,48].
As well as other plants, J. communis also receives popular names, both in our own and in foreign languages. For example, Havusa or Matsyagandha (Sanskrit); Arar, Abahal oe Habbul (Assamese); Hayusha (Bengali); juniper berry, or common juniper (English); Palash (Gujrati); havuber or havubair (Hindi); zimbro (Portuguese); padma beeja (Kannada); hosh (Marathi); havulber (Punjabi); hapusha, abhal or arar (Urdu) [21,23].
For curiosity, and despite this plant not having a strong presence in ancient mythology, it is considered a symbol of fertility in Syria. On the other hand, in the Old Testament, it is described that the juniper has an angelic presence, which sheltered the prophet Elijah from Queen Jezebel’s pursuit. Moreover, a posteriorly biblical tale described that during their flight to Egypt, the infant Jesus and his parents used juniper to hide from King Herod’s soldiers [49].
3. Phytochemical Composition of Juniperus communis L.
As mentioned before, J. communis L. species are composed of a myriad of constituents, including nonessential substances, i.e., phytochemicals [50]. These compounds are secondary metabolites produced by plants to promote their normal cellular metabolism and offer protection against biotic and abiotic factors, and consequent oxidative injury [51]. Additionally, they are considered the key contributors to the organoleptic characteristics (e.g., aroma and color) and health benefits exhibited by plants [52]. They can be divided into five major categories (Figure 2). Although the plants’ genotype mainly influences their quantitative and qualitative composition, their levels also depend on the plant’s age, ripeness degree, cultivation techniques, geographical location, and meteorological conditions [53,54].
3.1. Carotenoids and Chlorophylls
Although no studies have specifically reported the chlorophyll content of J. communis L. species, Rabska and colleagues [56] analyzed their total levels in fertilized and nonfertilized in both genders of this plant in autumn and winter (species not specified). The obtained data revealed nonfertilized plants had a lower concentration of total chlorophyll content than the fertilized ones (mean values of 5.0 versus (vs.) 7.4 mg/g in autumn and 3.6 vs. 4.8 mg/g in winter, respectively), and also lower amounts of total carotenoids (mean values of 0.64 and 0.95 mg/g for female and male, respectively, in autumn, and scores of 0.87 against 1.2 mg/g in winter). Focusing on gender, they observed that female plants had lower amounts of total chlorophyll compounds (values of 2.9 and 4.5 mg/g for female plants in autumn and winter, respectively, and 3.7 and 5.2 mg/g in autumn and winter, respectively, for the male ones) and carotenoid levels (values around 0.90 mg/g for female plants and around 1.0 mg/g for male, in autumn and winter, respectively). Without surprises, and regarding all the comparisons made, the authors also concluded that male and fertilized plants presented the highest levels of total chlorophyll and carotenoids (mean values of 4.3 and 1.3 mg/g, respectively).
This subclass of phytochemicals, highlighting carotenoids, possesses notable antioxidant potential and the ability to easily activate metabolic detoxification pathways, reducing the risk of appearance of several chronic and degenerative disorders [51,56].
3.2. Phenolic Compounds
Phenolics are the most predominant phytochemicals present in nature, and to date, about 10,000 different structures are currently described [57]. They are usually classified in (i) nonflavonoids and (ii) flavonoids [58]. The first ones can be further categorized into phenolic acids, including hydroxycinnamic and hydroxybenzoic acids, or in coumarins, lignans, or stilbenes [57]. On the other hand, flavonoids can be subdivided into isoflavones, coumestans, anthocyanidins, flavan-3-ols, flavanones, flavanonols (also called dihydroflavonols), flavones, or flavonols (Figure 2), depending on their structure [54]. This one comprises, at least, one phenol ring attached to one or more hydroxyl groups, and it is not only the main one responsible for dividing phenolics into different subclasses but also for conferring them a notable capacity to easily scavenge free radicals and reactive species; and to chelate metals, and in this way, counteract oxidative stress, diminish proinflammatory markers, and contribute to a healthy life state [57,59].
Focusing on phenolics found in J. communis L. species (Table 1), their levels depend on genotype, plant part, origin, age, gender, and solvent used to extract phenolics and perform the studies, but in a general way, they increase with latitude and plant age [56,60,61]. Additionally, male leaves and berries often present higher content in phenolic compounds than female ones [62].
Table 1.
Gender | Origin | Extract | Total Phenolic Compounds a | Total Flavonoid Content b |
Total Anthocyanin Content c | Total Tannin Content b | References | |
---|---|---|---|---|---|---|---|---|
Leaves | ||||||||
J. communis (var. alpina) |
n.s. | Serra Da Estrela, Portugal | Methanolic (100%, v/v) |
155.60 | 60.40 | [64] | ||
J. communis (var. alpina) |
n.s. | Yozgat, Turkey | Hydroethanolic (80% ethanol, v/v) | 4.36 | 7.05 | [61] | ||
J. communis (var. alpina) |
n.s. | Yozgat, Turkey | Aqueous | 169.27 | 24.30 | |||
J. communis (var. communis) |
Female | Rhodopes, Bulgaria | Methanolic (80% methanol, v/v) |
132.00 | [60] | |||
J. communis (var. communis) |
Female | Mountain Ozren, near Sarajevo, Bosnia, and Herzegovina | Methanolic (80% methanol, v/v) |
390.89 | 40.22 * | [62] | ||
J. communis (var. communis) |
Male | Mountain Ozren, near Sarajevo, Bosnia, and Herzegovina | Methanolic (80% methanol, v/v) |
544.09 | 48.06 * | |||
J. communis (var. communis) |
n.s. | Nainital, India | Hydroethanolic (70% ethanol, v/v) | 238.78 | [65] | |||
J. communis (var. communis) |
n.s. | Nainital, India | Hexane | 189.65 | ||||
J. communis (var. communis) |
n.s. | Nainital, India | Ethyl acetate | 315.33 | ||||
J. communis (var. communis) |
n.s. | Nainital, India | Aqueous | 205.33 | ||||
J. communis (var. oblonga pendula) |
Male | North Carolina, USA | Methanolic (80% methanol, v/v) |
91.00 | [60] | |||
J. communis (var. saxatiles) |
n.s. | Turkey | Hydroethanolic (80% ethanol, v/v) |
212.10 | [66] | |||
Berries | ||||||||
J. communis (var. alpina) |
n.s. | Yozgat, Turkey | Hydroethanolic (80% ethanol, v/v) |
Ripe berry: 11.92 Unripe berry: 130.92 |
Ripe berry: 2.56 Unripe berry: 17.57 |
[61] | ||
J. communis (var. alpina) |
n.s. | Yozgat, Turkey | Aqueous | Ripe berry: 4.36 | Ripe berry: 7.05 | |||
J. communis (var. communis) |
North-East Slovakia | Hydroethanolic (70% ethanol, v/v) |
Ripe berry: 6.87–42.23 | [67] | ||||
J. communis (var. communis) |
n.s. | Melbourne, Australia | Hydroethanolic (30% ethanol, v/v) |
Ripe berry: 9.08 | Ripe berry: 2.25 | Ripe berry: 3.48 * | [68] | |
J. communis (var. communis) |
n.s. | Quebec, Canada | Hydroethanolic (80% ethanol, v/v) |
Ripe berry: 99.20 b | Ripe berry: 0.47 | [69] | ||
J. communis (var. communis) |
n.s. | Serra Da Estrela, Portugal | Methanolic (100%, v/v) |
Ripe berry: 44.70 | [64] | |||
J. communis (var. communis) |
n.s. | Ağrı, Turkey | Methanolic (100%, v/v) |
Ripe berry: 59.17 | [70] | |||
J. communis (var. n.s.) |
n.s. | Pitesti hills, Romania | Hydroethanolic (50% ethanol, v/v) |
Ripe berry: 0.19 | Ripe berry: 51.09 d | [40] | ||
J. communis (var. saxatilis) |
n.s. | Yozgat, Turkey | Hydroethanolic (80% ethanol, v/v) |
Ripe berry: 21.00 | [66] | |||
J. communis (var. saxatilis) |
n.s. | Ankara, Turkey | Methanolic (100%, v/v) |
Ripe berry: 17.64 | [70] | |||
J. communis (n.s.) |
n.s. | Šara mountain in south Serbia | Chloroformic | 189.82 | 27.11 d | [50] | ||
J. communis (var. n.s.) |
n.s. | Šara mountain in south Serbia | Ethanolic | 189.82 | 42.85 d | |||
J. communis (var. n.s.) |
n.s. | Šara mountain in south Serbia | Ethyl acetate | 144.21 | 38.40 d | |||
Stems | ||||||||
J. communis (var. alpina) |
n.s. | Serra Da Estrela, Portugal | Methanolic (100%, v/v) |
221.30 | 79.30 | [64] |
n.s.: not specified; a mg equivalent of gallic acid (GAE) per g dry weight (dw); b mg quercetin equivalents per g dw; c mg cyanidin 3-glucoside equivalents per g dw; d mg quercetin 3-O-rutinoside equivalents per g dw; * mg of catechin equivalents per g dw.
Furthermore, and knowing the current interest in the biological potential of this plant, Brodowska et al. [63] conducted a study where they subjected J. communis (var. communis) L. berries to different ozone concentrations and time treatments. They verified that the treatment with ozone concentrations of 100 and 130 g/m3 for 30 min almost duplicated the phenolic content (15.47 and 12.91 mg catechin equivalent per g dry weight (dw), when compared to control (9.81 mg catechin equivalent per g dw), which consequently enhanced their antioxidant capacities positively.
Generally, the majority of phenolics reported in J. communis L. plant parts include 5-O-caffeoylquinic and quinic acids, catechin, epicatechin, amentoflavone, quercetin, luteolin, apigenin, and naringenin and their derivatives (Figure 3).
3.2.1. Hydroxycinnamic Acids
The presence of hydroxycinnamic acids on J. communis L. leaves is already known, and their levels mainly vary depending on genotype and local origin [71]. For example, 5-O-chlorogenic acid was found in ethanolic extracts (50% ethanol, v/v) of common J. communis L. (var n.s.) from Romania at mean values of 6.8 mg/g of dw [40]. On the other hand, quinic, cinnamic, ρ-coumaric, ferulic, and caffeic acids were detected in methanolic extracts (80% methanol, v/v) of var. saxatilis at concentrations of 11.1, 0.097, 0.088, 0.053, and <0.002 mg/g of dw, respectively [71]. Higher amounts of ρ-coumaric acid were found in methanolic extracts (80% methanol, v/v) of var. laxa (c.a. 5.95 mg/g of dw) [60].
Concerning J. communis L. berries, the presence of isoferulic acid, verbascoside, ρ-coumaric, cinnamic, quinic, and sinapic acid derivatives were reported on their ethanolic (30% ethanol, v/v) and methanolic extracts (70% methanol, v/v) [63,68].
Focusing on their biological potential, hydroxycinnamic acids present antimicrobial, antioxidant and anti-inflammatory effects, being able to easily interact with detoxification and inflammation-related pathways, preventing the appearance or attenuating the development of many chronic diseases [52,54].
3.2.2. Hydroxybenzoic Acids
The total content of hydroxybenzoic acids in J. communis L. leaves is relatively low [71]. As far as we know, protocatechuic acid was the only hydroxybenzoic acid reported in methanolic extracts (80% methanol, v/v) of J. communis var. laxa (c.a. 0.043 mg/g of dw) [60], while ρ-hydroxybenzoic, vanillic, gallic, and gentisic acids were found in methanolic extracts (80% methanol, v/v) of var. saxatilis at concentrations of 0.093, 0.060, 0.034, and 0.012 mg/g of dw, respectively [71]. Trace quantities of ρ-methylolphenol were also detected in methanolic extracts (100%, v/v) of J. communis (var. communis) [72]. Additionally, vestigial amounts of 2-hydroxybenzoic, 2,3-dihydroxybenzoic, ellagic and 4-O-methylgallic acids, and protocatechuic and gallic acid derivatives were reported in common J. communis L. berry ethanolic (30% ethanol, v/v) and methanolic (70% methanol, v/v) extracts [63,68].
As well as hydroxycinnamic acids, the hydroxybenzoic ones also display antimicrobial and antioxidant properties; however, they are less efficient given the lack of the CH=CH-COOH group and the double bond between carbons 7 and 8 [54].
3.2.3. Flavan-3-ols
Among flavan-3-ols, catechin was one of the most predominant in J. communis L. leaves, with values ranging from 1.73 (methanolic extracts (80% methanol, v/v) of var. laxa) to 5.53 (methanolic extracts (80% methanol, v/v) of var. saxatilis) and 219.01 (var. communis) mg/g of dw [60,71,72]. Moreover, vestigial amounts of epicatechin, epigallocatechin, and catechin were also reported in methanolic extracts (80% methanol, v/v) of var. saxatilis and var. communis (<1.5 mg/g of dw) [71,72]. Flavan-3-ols were also detected on J. communis berry ethanolic (30% ethanol, v/v) and methanolic (70% methanol, v/v) extracts, namely (+)-gallocatechin 3-O-gallate, (−)-epicatechin, 3′-O-methyl(−)-epicatechin 7-O-glucuronide, (−)-epigallocatechin, 4′-O-methylepigallocatechin, 4″-O-methylepigallocatechin 3-O-gallate, cinnamtannin A2, and procyanidins dimer B1 and trimer C1, at trace amounts [63,68].
This phenolic’s subclass presents several health benefits, namely notable antimicrobial, antiparasitic, antiviral, antioxidant, anti-inflammatory, antiproliferative, cardioprotective, and neuroprotective properties [51,58].
3.2.4. Flavonols
Within this subclass of compounds, the most abundant in J. communis L. leaves are quercetin aglycone and their derivatives, particularly quercetin 3-O-rutinoside [40,71,72]. In line with that, Fierascu et al. [40] reported quantities of 11.2 and 67.4 mg/g dw for quercetin and quercetin 3-O-rutinoside, respectively, in ethanolic extracts (50% ethanol, v/v) of common Romanian J. communis (var. n.s.). Methanolic extracts (80% methanol, v/v) of J. communis L. (var. saxatilis) also presented considerable amounts of quercetin 3-O-rutinoside (12.25 mg/g of dw) and small quantities of quercetin 3-O-glucoside (0.23 mg/g of dw), quercetin 3-O-rhamnoside (0.14 mg/g of dw), kaempferol 3-O-glucoside (0.021 mg/g of dw), and quercetin aglycone (<0.05 mg/g of dw) [71]. Regarding methanolic extracts (80% methanol, v/v) of var. laxa, they are also rich in quercetin 3-O-rutinoside (2.56 mg/g of dw) but present lower levels of kaempferol 3-O-rutinoside (0.22 mg/g of dw), kaempferol 3-O-glucoside (0.0097 mg/g dw), quercetin 3-O-glucoside (0.15 mg/g of dw), quercetin aglycone (0.11 mg/g dw), quercetin 3-O-rhamnoside (0.050 mg/g dw), isorhamnetin 3-O-rutinoside (0.079 mg/g dw), and isorhamnetin 3-O-glucoside (0.0037 mg/g dw) [60].
Concerning J. communis L. berry ethanolic (70% ethanol, v/v) and methanolic (70% methanol, v/v) extracts, they usually display many quercetin, kaempferol, myricetin, isorhamnetin, and patuletin derivatives in their composition [63,67]; particularly, methanolic extracts (100%, v/v) from var. communis and var. saxatilis present considerable amounts of quercetin hexoside (7.38 and 1.60 mg/g dw, respectively) [70]. Additionally, methanolic extracts (100%, v/v) of var. communis also exhibit trace amounts of quercetin 3-O-pentoside (1.01 mg/g dw) [70].
Given their chemical structure, flavonols are potent radical scavengers, and also show notable antimicrobial, anti-inflammatory, antiproliferative, and proapoptotic properties [54,68].
3.2.5. Flavones
J. communis L. leaves also present some flavones in their constitution, highlighting the presence of apigenin on ethanolic extracts (50% ethanol, v/v) (13.2 mg/g dw) [40], and amentoflavone (0.39 mg/g dw) in methanolic extracts (80% methanol, v/v) of var. saxatilis [71]. Furthermore, this last variety also displays trace amounts of luteolin and naringenin (<0.1 mg/g dw) [71]. Methanolic extracts (80% methanol, v/v) of J. communis L. var. laxa exhibit vestigial amounts of apigenin (0.030 mg/g dw), luteolin 7-O-glucoside (0.011 mg/g dw), apigenin 7-O-glucoside (0.095 mg/g dw), and naringenin 7-O-glucoside (0.025 mg/g dw) [60]. The presence of apigenin 7-O-glucoside was also detected in methanolic extracts (100%, v/v) of var. communis [72]. On the other hand, apigenin, chrysoeriol, gossypetin derivatives, cirsilineol, isorhoifolin, luteolin, luteolin 3-O-galactoside, amentoflavone, and cupressoflavone were reported in J. communis L. berries [63,68,70]. For example, methanolic extracts (80% methanol, v/v) of berries from var. communis display considerable amounts of gossypetin hexoside and gossypetin hexoside-pentoside (amounts of 3.17 and 0.93 mg/g dw, respectively), hypolaetin 7-pentoside (ca., 7.99 mg/g dw), and isoscutellarein 7-O-pentoside (2.59 mg/g dw), while methanolic extracts (80% methanol, v/v) of var. saxatilis are richer in isoscutellarein 8-O-hexoside (2.44 mg/g dw), amentoflavone (0.95 mg/g dw), and methylbiflavone (0.85 mg/g dw) [70].
Although flavones are less effective in diminishing free radicals and reactive species levels due to the lack of the hydroxyl group at carbon 3 than other flavonoids, they display antimicrobial, antioxidant, and anticancer effects, as well as a notable ability to regulate lipid metabolism [54,64].
3.2.6. Coumarins and Flavanones
Methanolic extracts (80% methanol, v/v) of J. communis L. leaf var. saxatilis present trace amounts of umbelliferone—which is a coumarin derivative—in its composition (c.a., 0.253 mg/g dw) [71], while methanolic extracts (80% methanol, v/v) of J. communis L. leaf var. laxa contain small quantities of taxifolin (flavanones) (0.0063 mg/g dw) [60].
Without surprises, both subclasses exhibit various biological activities, namely antioxidant, anti-inflammatory, anticancer, and anticoagulant properties [54,61]. Additionally, flavanones can act synergistically with flavones, inhibiting the development of estrogen-dependent colon cancers [25].
3.2.7. Anthocyanins
Although J. communis L. leaves do not present anthocyanins, ethanolic extracts (30% ethanol, v/v) of their berries present some anthocyanins in their composition. Around 17 different anthocyanins were detected in berries, grouped as glycosides of cyanidin, delphinidin, peonidin, and pelargonidin [68].
Given their multiple hydroxyl groups, anthocyanins are potent radical scavengers, and also present notable anti-inflammatory abilities, being able to interact with related pathways, increase antioxidant defences, and diminish proinflammatory biomarkers, and in this way, prevent the occurrence of many oxidative-stress-related disorders [54,59].
3.3. Volatile Organic Compounds (VOC’s)
J. communis L. parts, namely their essential oils, present many volatile organic compounds (VOCs) in their composition, particularly the presence of monoterpene hydrocarbons, oxygenated monoterpenes, sesquiterpene hydrocarbons, and oxygenated sesquiterpenes [40,53]. As well as other phytochemicals, their levels also depend on genotype, origin, cultivation methods, meteorological conditions, and extraction techniques. Even so, among the species, monoterpenes such as α-pinene, β-pinene, and β-myrcene are the most commonly found, followed by some sesquiterpenes compounds, namely germacrene D (Figure 4) [73,74,75].
A total of 57 different VOCs were detected in leaf ethanolic extracts (50:50, v/v), with pimaric acid being the predominant one (29.74% of total VOCs), followed by α-pinene (14.86% of total VOCs), β-myrcene (6.99% of total VOCs), bicyclosesquiphellandren (6.87% of total VOCs), and β-pinene (5.29% of total VOCs) [40]. On the other hand, extracts of var. communis exhibited higher percentages of limonene (26.12%), benzene (15.62%), β-myrcene (9.08%), and β-pinene (7.30%) [76]. Focusing on var. alpina, the predominant ones in their ethanolic extracts (50% ethanol, v/v) were δ-cadinene (12.80%), α-pinene (11.0%), germacrene D (9.30%), and borneol (8.60%) [77].
Regarding essential oils of their leaves, in the var. communis, α-pinene was also the most found (34.87% of total VOCs), followed by citronellyl acetate (14.26%), limonene (10.72%), and terpinolene (10.65%). Additionally, vestigial amounts (<6.21%) of ρ-cymene, elemene, cadinene, cyclohexane, cedrol, and caryophyllene were also reported [73]. α-Pinene was also the most abundant compound detected in different leaves of var. communis from different regions of the United States of America (USA) (66.6–75.2%) [78].
On the other hand, in leaves of var. communis from Serbia, sabinene was the main one reported (39.40%), followed by α-pinene (13.3%) and β-myrcene (4.70%) [79], whereas in var. alpina from France, limonene was clearly the most predominant (30.90%), followed by α-pinene (24.40%), β-phellandrene (12.60%), β-myrcene (3.60%), and α-phellandrene (3.60%) [80]. Similar percentages of α-pinene were reported on var. saxatilis (23.60%); additionally, this species was also shown to possess considerable percentages of α-cadinene (10.71%), sabinene (9.53%), germacrene D (7.25%), α-murolene (6.58%), and γ-cadinene (5.87%) [71,79].
Focusing on the berries of Portuguese J. communis var. communis, the main VOCs found in their essential oils were α-pinene (41.60%), β-pinene (27.60%), limonene (6.40%), β-myrcene (5.70%), and trans-pinocarveol (1.90%) [81]. A similar profile was found on Greek oil berries [82]. On the other hand, Iranian J. communis oils from the same species showed lower percentages of α-pinene (19.90%), and higher content of sabinene (36.8%) and limonene (10.60%) [83]. Additionally, essential oils from Iran also contained considerable percentages of germacrene D (8.10%) and terpinen-4-ol (3.60%) [83]. On the other hand, in Juniper oil berry var. alpina from Virginia (USA), α-pinene was the predominant one (20.00%), followed by δ-cadinene (10.40%), limonene and β-myrcene (8.70 and 8.50%, respectively) and borneol (8.00%) [82]. a-Pinene was also the main reported in var. alpina from Portugal (77.4%), followed by trace amounts of β-phellandrene (4.80%), α-terpinyl acetate (2.90%), and β-myrcene (2.60%) [84]. On the other hand, in oil berry var. alpina from France, limonene was the main found (49.30%), followed by α-pinene (22.10%) and β-myrcene (6.30%) [80]. Regarding oil berries, a high percentage of α-pinene was detected (51.40%) in common Romanian J. communis; additionally, myrcene, sabinene, limonene, and β-pinene were also found at percentages of 8.30, 5.80, 5.10, and 5.00%, respectively [32].
The combination of all of these results is evidence that local origin influences the phytochemical profile. Additionally, Gonny et al. [80] determined the VOC profile of J. communis woods and roots of var. alpina. For woods, α-terpinyl acetate (9.10%) and α-terpineol (8.4%) were the predominant ones, while for roots, a high percentage of cedrol (37.70%) and cinnamyl acetate (11.50%) were found.
VOCs have been gaining great interest owing to their remarkable antimicrobial, antioxidant, anti-inflammatory, and anticancer properties, being able to attenuate, or even mitigate, the development of cardiovascular disorders and neuropathologies, and also ameliorate the mental state of individuals [85].
4. Biological Potential of Juniperus communis Linnaeus
Since ancient times, J. communis parts have been largely used as antiseptics, contraceptives, and diuretics, and as a remedy to treat colds, chest complaints, rheumatism, headaches, dermatological and respiratory ailments, and kidney and urinary infections [38,39,85]. Given the aforementioned, it is not surprising that this plant is a focus of continuous studies to discover its full potential.
To date, several reports have highlighted its antimicrobial, antifungal, antioxidant, anti-inflammatory, and antidiabetic potential, as well as its anticarcinogenic, hepatoprotective, neuronal, and renal effects, as described in Figure 5 and Table 2, Table 3 and Table 4 [34,38,40,66,86,87,88]. Next, a summary of the main studies already published concerning the health-promoting properties of this plant will be presented.
Table 2.
Part of the Plant | Origin | Subspecies/Variety | Method | Inhibited Species | References |
---|---|---|---|---|---|
Antimicrobial activity | |||||
Essential oils | |||||
Berries | Poland | n.s. | Disc diffusion | Staphyllococcus aureus, Serratia marcenscens, Enterobacter cloace, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumanii, Listeria monocytogenes, and Candida albicans | [89] |
Needles | Portugal | var. alpina | MIC and MLC | Epidermophyton floccosum, Microsporum canis, M. gypseum, Trichophyton mentagrophytes, T. mentagrophytes var. interdigitale, T. rubrum, and T. verrucosum | [90] |
Needles and berries | Italy | var. communis | MIC | C. albicans, S. aureus, and P. aeuroginosa | [91] |
Plant material (leaves and stems) | Iran | n.s. | Disc diffusion | S. aureus, P. aeruginosa, and E. coli | [36] |
Berries | Slovenia | n.s. | Biofims assay | Campylobacter jejuni, L. monocytogenes | [96] |
Plant material (undifferentiated) | Slovenia | n.s. | Disc diffusion | S. aureus and C. albicans | [92] |
Berries | Spain | n.s. | MIC | E. coli, Proteus mirabilis, K. pneumoniae, P. aeruginosa and Morganella morganii, MRSA, and L. monocytogenes | [75] |
Berries | Portugal | n.s. | MIC and MLC | B. cereus, B. subtilis, E. aerogenes, E. faecalis, E. coli, K. pneumoniae, Proteus mirabilis, P. aeruginosa, Salmonella typhimurium, S. aureus, and C. albicans | [81] |
Leaves | Croatia | n.s. | Disc diffusion, MIC, and MLC | 16 species of bacteria and 14 species of fungus | [26] |
Berries | Serbia | n.s. | Disc diffusion, MIC, MLC, and in vivo adhesion assay | S. aureus, MRSA, E. faecalis, L. monocytogenes, E. coli, S. flexneri, S. enteritidis, P. aeruginosa, Aspergillus fumigatus, A. versicolor, A. ochraceus, A. niger, Trichoderma viride, Penicillium funiculosum, P. ochrochloron, and P. verrucosum var. cyclopium | [93] |
Plant material (leaves and branches) | Egypt | n.s. | MIC | S. aureus, E. coli, and C. albicans | [94] |
Plant material | Croatia | n.s. | MIC and biofilm assay | Mycobacterium avium, M. intracellulare, and M. gordonae | [97,98] |
Phenolic-rich extracts | |||||
Berries | Slovenia | n.s. | Biofilms assay | C. jejuni, L. monocytogenes | [96] |
Plant material | Italy | n.s. | Disc diffusion and MIC | Actinomyces viscosus, Lactobacillus casei, Streptococcus mutans, S. sobrinus, and general oral microbiota | [99] |
Berries | Turkey | n.s. | Disc diffusion and MIC | S. epidermidis, S. aureus, B. subtilis, P. aeruginosa, E. coli, and C. albicans | [100] |
Leaves | Turkey | var. communis and var. saxatilis | MIC | S. aureus | [101] |
Leaves | Poland | n.s. | Disc diffusion |
K. pneumoniae, S. enteritidis, P. aeruginosa, A. baumannii, E. faecium, S. aureus, L. fermentum, Clostridium butyricum, L. monocytogenes, B. coagulans, C. utilis, Aspergillus spp., and Fusarium spp. |
[102] |
Stem (branches) | Italy | var. communis and var. saxatilis | Biofilm formation | S. aureus | [103] |
Berries | Turkey | var. communis and var. saxatilis | MIC and MLC | S. aureus, S. epidermidis, E. hirae, B. subtilis, E. coli, P. mirabilis, P. aeruginosa, C. albicans, and C. parapsilosis | [70] |
Leaves | India | n.s. | MIC | E. coli, S. aureus, and K. pneumoniae | [104] |
Antiparasitic activity | |||||
Essential oils | |||||
Stems and leaves | France | n.s. | Radioactive micromethod | Two different strains of Plasmodium falciparum, which were chloroquine-resistant (FcBl) and chloroquine-sensitive (Nigerian) strains | [105] |
n.s.: not specified; MIC: Minimal inhibitory concentration; MLC: Minimal lethal concentration.
Table 3.
Part of the Plant | Origin | Extract | Subspecies/ Variety |
Experimental Model | Effect | References |
---|---|---|---|---|---|---|
In vitro assay | ||||||
Berries | Romania | Ethanolic (50% ethanol, v/v) |
n.s. | Capacity to scavenge DPPH● | IC50 value of 1.42 µg/mL | [32,40,50,61,67] |
Serbia | Ethanolic | IC50 value of 28.55 µg/mL | ||||
Ethyl acetate | IC50 value of 106.44 µg/mL | |||||
Chloroform | IC50 value of 257.66 µg/mL | |||||
Poland | Methanolic (70%, methanol v/v) |
IC50 values from 6.86 to 13.66 µg/L | ||||
Essential oils | IC50 varying from 1.27 to 4.25 µg/L | |||||
Turkey | Methanolic | var. saxatilis | IC50 value of 1.84 mg/mL | |||
var. communis | IC50 value of 0.63 mg/mL | |||||
Ethanolic (80% ethanol, v/v) |
var. alpina | Inhibitory percentages of 33.25, 34.27, and 36.26% at 0.5, 1, and 2 mg/mL, respectively | ||||
Aqueous | Inhibitory percentages of 48.40, 63.29, and 82.03% at 0.5, 1, and 2 mg/mL, respectively | |||||
Poland | Methanolic (70% methanol, v/v) |
n.s. | Reducing power potential | Values ranging 6.90 and 10.70 mM FeSO4 × 7H2O | [61,63,67,70] | |
Essential oils | Values ranging from 0.47 and 1.11 mM FeSO4 × 7H2O | |||||
Turkey | Methanolic | var. communis | IC50 value of 12.82 mg/mL | |||
12.82 ascorbic acid equivalent/mL | ||||||
var. saxatilis | IC50 value of 64.14 mg/mL | |||||
64.14 ascorbic acid equivalent//mL | ||||||
Ethanolic (80% ethanol, v/v) |
var. alpina | Inhibitory percentages of 0.083, 0.095, and 0.203% at 0.5, 1, and 2 mg/mL, respectively | ||||
Aqueous | Inhibitory percentages of 0.424, 0.689, and 1.371% at 0.5, 1, and 2 mg/mL, respectively | |||||
Poland | Methanolic (70% methanol, v/v) |
n.s. |
β-carotene bleaching test |
β-carotene inhibitory potential varying from 24.36 to 30.63% | [63] | |
Essential oils | n.s. | β-carotene inhibitory potential varying from 1.19 to 2.39% | ||||
Turkey | Methanolic | var. saxatilis | Protect liposomes from lipid peroxidation | IC50 value of 120.07 µg/mL | [70] | |
var. communis | IC50 value of 4.44 µg/mL | |||||
Turkey | Methanolic | var. saxatilis | Ferrous ion (Fe2+)-chelating activity | Chelating ability around 30% at 2 mg/mL | [32,61,69] | |
var. communis | Chelating ability around 15% at 2 mg/mL | |||||
Ethanolic (80% ethanol, v/v) |
var. alpina | Inhibitory percentages of 4.88, 14.86, and 32.82% at 0.5, 1, and 2 mg/mL, respectively | ||||
Aqueous | Inhibitory percentage of 0.83% at 2 mg/mL | |||||
Canada | Ethanolic (80% ethanol, v/v) |
var. communis | Capacity to scavenge peroxyl radicals | 3876 µM Trolox equivalents at 1 mg/mL | [32,66] | |
n.s. | Essential oil | n.s. | Capacity to scavenge ABTS•+ species | IC50 value of 10.96 µg/mL | ||
Turkey | Ethanolic (80% ethanol, v/v) |
var. saxatilis | Capacity to scavenge ABTS•+ species | Inhibitory percentages of 42.5%, respectively at 3 mg/mL | ||
n.s. | Essential oil | n.s. | Capacity to scavenge hydroxyl radicals | IC50 value of 0.0066 µg/mL | [32] | |
n.s. | Essential oil | n.s. | Capacity to scavenge superoxide anions | IC50 of 0.822 µg/mL | [32,61] | |
Turkey | Ethanolic (80% ethanol, v/v) |
var. alpina | Inhibitory percentages of 20.07, 21.97, and 17.80% at 0.5, 1, and 2 mg/mL, respectively | |||
Aqueous | var. alpina | Inhibitory percentages of 5.49, 10.61, and 11.17% at 0.5, 1 and 2 mg/mL, respectively | ||||
Crushed berries | Slovakia | Ethanolic (70% ethanol, v/v) |
n.s. | Capacity to scavenge hydroxyl radicals | Inhibitory values varying from 65.59 to 88.12% (recalculated by dry matter (DM), from 3.06 to 5.75%/g DM) | [67] |
Noncrushed berries | Slovakia | Ethanolic (70% ethanol, v/v) |
n.s. | Inhibitory values varying from 15.52 and 32.85% (recalculated by dry matter (DM), from 1.20 to 20.05%/g DM) for | ||
Unripe berries | Turkey | Ethanolic (80% ethanol, v/v) |
var. alpina | Capacity to scavenge superoxide anions | Inhibitory percentages of 14.58, 10.99, and 18.37% at 0.5, 1, and 2 mg/mL, respectively | [61] |
Capacity to scavenge DPPH● | Inhibitory percentages of 46.21, 57.32, and 73.75% at 0.5, 1, and 2 mg/mL, respectively | [32,61] | ||||
Capacity to chelate metals | Inhibitory percentages of 6.32, 5.04, and 16.59% at 0.5, 1, and 2 mg/mL, respectively | [61] | ||||
Ferric-reducing antioxidant power | Inhibitory percentages of 0.288, 0.504, and 0.855% at 0.5, 1, and 2 mg/mL, respectively | |||||
Leaves | India | Ethanolic (70% ethanol, v/v) |
n.s. | Capacity to scavenge DPPH● | IC50 value of 213 µg/mL | [60,61,65,79,107] |
Aqueous | var. communis | IC50 value of 347 µg/mL | ||||
Ethyl acetate | IC50 value of 177 µg/mL | |||||
Turkey | Ethanolic (80% ethanol, v/v) |
var. alpina | Inhibitory percentages of 66.62, 83.06, and 91.40% at 0.5, 1, and 2 mg/mL, respectively | |||
Aqueous | Inhibitory percentages of 34.92, 35.56, and 37.29% at 0.5, 1, and 2 mg/mL, respectively | |||||
Bulgaria | Methanolic (80% methanol, v/v) |
var. Oblonga Pendula | IC50 value of 258 µg/mL | |||
Serbia | Essential oil | var. communis | IC50 value of 660 µg/mL | |||
Serbia | Essential oil | var. saxatilis | Potential to chelate metals | IC50 value of 320 µg/mL | [61,107] | |
India | Ethyl acetate | var. communis | IC50 value of 261 µg/ mL |
|||
Turkey | Acetate | n.s. | Inhibitory effect of 6.05% at 1 mg/mL | |||
Aqueous | var. alpina | Inhibitory percentages of 9.06, 12.39, and 38.40% at 0.5, 1, and 2 mg/mL, respectively | ||||
Turkey | Ethanolic (80% ethanol, v/v) |
var. alpina | Capacity to scavenge superoxide anions | Inhibitory percentages of 20.26, 25.00, and 25.38% at 0.5, 1, and 2 mg/mL, respectively | [61,71] | |
Turkey | Ethanolic (80%, ethanol v/v) |
var. alpina |
Ferric-reducing antioxidant power | Inhibitory percentages of 0.681, 1.278, and 1.971% at 0.5, 1, and 2 mg/mL, respectively | ||
Aqueous | Inhibitory percentages of 0.121, 0.120, and 0.154% at 0.5, 1, and 2 mg/mL, respectively | |||||
Serbia | Distilled extracts | var. saxatilis | Reduction capacity of 78.77 mg of ascorbic acid equivalents per g of dry matter | |||
Serbia | Distilled extracts | var. saxatilis | Lipid-peroxidation inhibitory potential | IC50 value of 540 µg/mL | [71] | |
Essential oils | IC50 value of 2440 µg/mL | |||||
Turkey | Ethanolic (80% ethanol, v/v) |
var. saxatilis | Capacity to scavenge ABTS•+ species | Inhibitory percentage of 99.5 at 3 mg/mL | [66] | |
Shoots | Poland | Crude extract | n.s. | Antioxidant-enzyme activity and reactive oxygen species in vitro assays | ↑↑ the activity of intracellular antioxidant enzymes superoxide dismutase and catalase ↓↓ reactive oxygen species |
[56] |
Turkey | Acetone | n.s. | Capacity to chelate metals | Inhibitory percentage of 6.05% at 1 mg/mL | [107] | |
Ethyl acetate | Inhibitory percentage of 22.59 at 1 mg/mL | |||||
Ethanolic (75% ethanol, v/v) |
Inhibitory percentage of 12.31% at 1 mg/mL | |||||
Twigs | Spain | Essential oil | n.s. | Peroxy-radical-induced oxidation inhibition | 120 µmol Trolox/gram of essential oil | [53] |
Hops | Australia | Ethanolic (30% ethanol, v/v) |
n.s. | Ferric ion-reducing antioxidant power | 4.17 mg of ascorbic acid equivalents per g | [68] |
Capacity to scavenge DPPH● | 9.26 mg of ascorbic acid equivalents per g | |||||
Capacity to scavenge ABTS•+ species | 49.54 mg of ascorbic acid equivalents per g | |||||
Plant material (twigs, leaves, and berries) | Spain | Essential oil | n.s. | Reducing power assay | IC50 values from 135 to 970 µg/mL | [75] |
Spain | Essential oil | n.s. | Inhibition of oxidation process | IC50 values from 324.76 to 1563.29 µg/mL | ||
In vivo assay | ||||||
Leaves | India | Methanolic | n.s. | Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg | ↑↑ in reduced glutathione ↓↓ levels of TBARS |
[19] |
Romania | Essential oil | n.s. | Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats | ↑↑ superoxide dismutase and catalase enzymes, and glutathione peroxidase activity | [85] |
n.s.: not specified; IC50: half-maximal inhibitory concentration; TBARS: thiobarbituric acid-reactive substances, DPPH●: 2,2-diphenyl-1-picrylhydrazyl radical; ABTS•+: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; ↑↑: increase; ↓↓: reduction.
Table 4.
Part of the Plant | Origin | Extract | Subspecies/ Variety |
Experimental Model | Effect | References |
---|---|---|---|---|---|---|
Anti-inflammatory and antinociceptive properties | ||||||
In vitro assay | ||||||
Plant parts | Sweden | Aqueous | n.s. | Prostaglandin biosynthesis assay Platelet activating factor-induced exocytosis assay |
↓↓ prostaglandins by 55% at 200 µg/mL ↓↓ platelet activating factor-induced exocytosis by 78% at 250 µg/mL |
[25] |
Woods | Austria | Methylene chloride | n.s. | 12(S)-lipoxygenase assay | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 54.0% at 100 µg/mL, 66.2 and 76.2%, | [88] |
Berries | Austria | Methylene chloride | n.s. | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 66.2% at 100 µg/mL | ||
Ethyl acetate | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 76.2% at 100 µg/mL | |||||
Plant material (twigs, leaves, and fruits) | Spain | Essential oil | n.s. | Inhibition of nitric oxide production in lipopolysaccharide-activated murine macrophage RAW 264.7 cells | IC50 values from 23.98 to 84.80 µg/mL | [75] |
In vivo assays | ||||||
Berries | Italia | Hydroethanolic (80% ethanol, v/v) |
var. communis | Effects on the inhibition of writhing carrageenin foot edema in male Wistar rats after 7 days of treatment at doses of 100 and 200 mg/kg | ↓↓ carrageenin-foot edema by 60% and 79% at 100 and 200 mg/kg, respectively | [113] |
Turkey | Aqueous | 12.8% inhibition (berries) | [114] | |||
Berries, leaves, and stems | Turkey | Methanolic | var. communis | 18.5% inhibition (stems) 3.9% inhibition (berries) 18.5% inhibition (leaves) |
||
Aqueous | var. saxatilis | 9.1% inhibition (berries) 7.8% inhibition (leaves) |
||||
Methanolic | 30.5% inhibition (berries) 35.2% inhibition (leaves) |
|||||
Aqueous | var. communis | Effects on stimulating response latency in male Swiss albino mice using a hot plate after administration of 100 mg/kg of extract | 4.27% inhibition (stems) 5.36% inhibition (berries) 4.29% inhibition (leaves) |
|||
Methanolic | 4.40% inhibition (stems) 4.11% inhibition (berries) 5.16% inhibition (leaves) |
|||||
Aqueous | var. saxatilis | 3.26% inhibition (stems) 4.32% inhibition (berries) 5.13% inhibition (leaves) |
||||
Methanolic | 3.13% inhibition (stems) 4.05% inhibition (berries) 5.31% inhibition (leaves) |
|||||
Aqueous | var. communis | Effects on carrageenin-induced hind-paw edema in male Swiss albino mice after 360 min of 100 mg/kg extract administration | 65.9% inhibition (stems) 65.1% inhibition (berries) 65.4% inhibition (leaves) |
|||
Methanolic | 54.3% inhibition (stems) 65.8% inhibition (berries) 54.8% inhibition (leaves) |
|||||
Aqueous | var. saxatilis | 69.6% inhibition (stems) 51.9% inhibition (berries) 53.6% inhibition (leaves) |
||||
Methanolic | 65.7% inhibition (stems) 43.4% inhibition (berries) 45.3% inhibition (leaves) |
|||||
Methanolic | var. saxatilis | Effects on PGE2-induced hind-paw edema effects in male Swiss albino mice after 360 min of 100 mg/kg extract administration | 17.6% inhibition (stems) 16.5% inhibition (berries) 16.8% inhibition (leaves) |
|||
Leaves | India | Methanolic | n.s. | In vivo study involving different nociceptive assays (acetic acid-induced writhing, formalin and tail-flick tests) in Swiss albino mice at 100 and 200 mg/kg | ↓↓ writhing response and the late phase related with the formalin test Act centrally since the extract and pethidine effects were blocked by naloxone in the tail-flick test |
[29] |
Berries | Romania | Hydroethanolic microemulsions | n.s. | Effects on paw edema in dextran-induced inflammation Wistar rats’ model | ↓↓ paw edema | [40] |
Berries | Romania | Hydroethanolic microemulsions | n.s. | Kaolin-induced inflammation in Wistar rats’ model | ↓↓ interleukins -1β and 6 expression ↓↓ tumor necrosis factor alfa |
|
Antidiabetic, antihypercholesterolemic and antihyperlipidemic effects | ||||||
In vitro assays | ||||||
Fruits | Turkey | Hydroethanolic (80% ethanol, v/v) |
var. saxatilis | Capacity to inhibit α-amylase activity | Inhibitory value of 29.8% at 3 mg/mL | [66] |
Capacity to inhibit α-glucosidase activity | IC50 value of 4.4 µg/mL | |||||
Leaves | Turkey | Hydroethanolic (80% ethanol, v/v) |
var. saxatilis | Capacity to inhibit the α-amylase activity | Inhibitory value of 84.3% at 3/mg/mL | |
Capacity to inhibit the α-glucosidase activity | IC50 value of 53.6 µg/mL | |||||
Plant material | United Kingdom | Aqueous | n.s. | Effects on glucose movement | ↓↓ glucose diffusion by 6% at 50 g/L | [124] |
In vivo assays | ||||||
Berries | United Kingdom | n.s. | Streptozotocin-induced diabetic mice models for 40 days at doses of 1 g/400 mL | ↓↓ polydipsia Prevent weight losses |
[125] | |
Spain | Aqueous | n.s. | Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at doses of 250 and 500 mg/kg | ↓↓ hypoglycemia in normoglycemic rats | [126] | |
Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at 125 mg/kg | ↓↓ blood glucose levels and mortality index Prevent weight losses |
|||||
Turkey | Oil dissolved in 0.5% of sodium carboxymethyl cellulose | n.s. | Effects on albino Wistar rats after 30 days of treatment at doses of 50, 100 and 200 mg/kg | ↓↓ total cholesterol, oxidized low-density lipoprotein, alanine aminotransferase, and aspartate transaminase levels ↑↑ blood urea nitrogen and creatinine levels |
[33] | |
Plant | n.s. | Methanolic extracts | n.s. | Effects on streptozotocin-nicotinamide induced diabetic rats after 21 days of treatment at doses of 100 and 200 mg/kg | ↓↓ blood glucose levels, total cholesterol, triglycerides, low-density lipoprotein, and very-low-density lipoprotein cholesterols ↑↑ high-density lipoprotein cholesterol |
[31] |
Herbal preparation also composed of Juniperus. communis | Croatia | Hydroethanolic (60% ethanol, v/v) |
n.s. | Effects on alloxan-induced nonobese diabetic NOD mice after 7 days of treatment at 20 mg/kg | ↓↓ glucose and fructosamine levels | [127] |
Antiproliferative effects | ||||||
In vitro assays | ||||||
Berries | Nepal | Aqueous | n.s. | Effects on OECM-1 human gingival squamous cancer cells after 24 h of exposure | Induce apoptosis, exhibiting an IC50 value of 46.20 µg/mL | [128] |
Plant material | n.s | Aqueous | n.s | Effects on CE81T/VGH human esophageal squamous cell carcinoma after 24, 48 and 72 h of exposure | Induce cell cycle arrest at the G0/G1 phase by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways IC50 values of 68.41, 64.33, and 60.07 µg/mL after 24, 48, and 72 h of exposure, respectively |
[39] |
Effects on CE48T/VGH human esophageal epidermoid carcinoma after 24, 48, and 72 h of exposure | Induce cell-cycle arrest at the G0/G1 phase, by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways IC50 values of 69.38, 56.96, and 36.10 µg/mL after 24, 48, and 72 h of exposure, respectively |
|||||
USA | Distilled extracts | Effects on B16/F10 melanoma cells after 24 and 48 h of exposure | Induced apoptosis, decreased angiogenesis and metastasis, and diminished cancer stem-cell expression IC50 values of 27 and 44 µg/mL, after 24 and 48 h of exposure, respectively |
[73] | ||
Leaves | Turkey | Methanolic | n.s. | Effects on C6 rat brain tumor and HeLa human cervix carcinoma cells after 24 h of exposure | IC50 value of 28.43 µg/mL (C6 rat brain tumor) IC50 value of 32.96 µg/mL (HeLa cancer cells) |
[72] |
Aerial parts | Egypt | Methanolic | n.s. | Effects on PC3 human prostate, HCT 116 human colon, and MCF7 breast cancer cells after 24 h of exposure | IC50 value of 23.8 µg/mL (PC3 cancer cells) IC50 value of 37.6 µg/mL (HCT 116 cancer cells) IC50 value of 23.8 µg/mL (MCF7 cancer cells) |
[129] |
Plant material | New Mexico, USA | Aqueous | n.s. | Effects on MCF-7/AZ breast cancer cells after 24 h of exposure | IC50 value of 50 µg/mL | [75,130] |
Spain | Essential oil | n.s. | Effects on NCI-H460 lung, MCF-7 breast, AGS gastric, and Caco-2 cancer cells after 24 h of exposure | IC50 values varying from 41.99 to 44.87 µg/mL (NCI-H460 cancer cells) IC50 values varying from 30.88 to 163.99 µg/mL (MCF-7 cancer cells) IC50 values varying from 132.68 to 302.86 µg/mL (AGS cancer cells) IC50 values varying from 107.65 to 230.79 µg/mL (Caco-2 cancer cells) |
||
Berries | Australia | Methanolic | n.s. | Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure | IC50 value of 1383 µg/mL (Caco-2 cancer cells) IC50 value of 2592 µg/mL (HeLa cancer cells) |
[131] |
Aqueous | n.s. | Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure | IC50 value of 1516 µg/mL (Caco-2 cancer cells) IC50 value of 2157 µg/mL (HeLa cancer cells) |
|||
Serbia | Essential oil and Distilled extracts | var. saxatilis | Effects on A549 human lung adenocarcinoma epithelial cells after 24 h of treatment after 24 h of exposure | Induced apoptosis and arrested cell cycle in G2/M IC50 value of 69.4 µg/mL (essential oil) IC50 value 1270 µg/mL (distilled extract) |
[71] | |
USA | Distilled extracts | n.s. | Effects on HepG2 human hepatocellular cancer cells after 24, 48, and 72 h of exposure | IC50 values of 48.9, 42.3, and 43.9 µg/mL, after 24, 48, and 72 h of exposure, respectively | [132,133] | |
Effects on Mahlavu human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure | IC50 values of 64.9, 58.5, and 59.4 µg/mL, after 24, 48, and 72 h of exposure, respectively | |||||
Effects on J5 human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure | IC50 values of 74.2, 67.2, and 53.2 µg/mL, after 24, 48, and 72 h of exposure, respectively | |||||
Effects on HT-29 colon cancer cells after 24, 48, and 72 h of exposure | Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 Induced cell apoptosis via the extrinsic (FasL/Fas/caspase-8) and intrinsic (Bax/Bcl-2/caspase-9) apoptotic pathways IC50 values of 66.71, 60.02, and 54.32 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Effects on CT-26 colon cancer cells after 24, 48, and 72 h of exposure | Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 Induced cell apoptosis via the extrinsic (FasL/Fas/caspase-8) and intrinsic (Bax/Bcl-2/caspase-9) apoptotic pathways IC50 values of 27.8, 22.7, and 27.3 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Leaves and branches | Wyoming, USA | Essential oil | n.s. | Effects on SH-SY5Y human neuroblastoma cells after 24 h of exposure | IC50 value of 53.7 µg/mL | [134] |
Seed cones | Serbia | Essential oil | var. saxatilis | Effects on HT-29 and HCT116 colon cancer cells after 24 h of exposure | IC50 value 125 µg/mL (HT-29) IC50 value of 62.5 µg/mL (HCT116) |
[93] |
Distilled extracts | IC50 value 625 µg/mL (HT-29) IC50 value of 1250 µg/mL (HCT116) |
|||||
Roots | China | Acetone | n.s. | Effects on N18 neuroblastoma cell lines after 24 and 48 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 values of 61.11 and 68.94 µg/mL, after 24 and 48 h of exposure, respectively |
[135] |
Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 24 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 value of 67.04 µg/mL (DBTRG-05MG glioblastoma cells) IC50 value of 63.3 µg/mL (G5T/VGH glioblastoma cells) IC50 value of 57.14 µg/mL (GBM8401glioblastoma cells) IC50 value of 58.45 µg/mL (GBM8901 glioblastoma cells) IC50 value of 69.97 µg/mL (RG2 glioblastoma cells) |
|||||
Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 48 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 value of 49.46 µg/mL (DBTRG-05MG glioblastoma cells) IC50 value of 67.85 µg/mL (G5T/VGH glioblastoma cells) IC50 value of 46.68 µg/mL (GBM8401glioblastoma cells) IC50 value of 55.49 µg/mL (GBM8901 glioblastoma cells) IC50 value of 53.8 µg/mL (RG2 glioblastoma cells) |
|||||
In vivo assays | ||||||
Plant | USA | Distilled extracts | n.s. | Effects on melanoma tumor model in C57BL/6 mice after 23 days of treatment at a dose of 200 mg/kg | Cell-cycle arrest at the G0/G1 phase ↓↓ tumor size by 45.2%, B-cell lymphoma-2 (Bcl-2), procaspases 8 and 9 and higher levels of Bcl-2-associated X protein, apoptosis-inducing factor, cell-surface death receptor Fas and Fas ligand when compared to untreated control |
[73] |
Berries | USA | Distilled extracts | n.s. | Effects in BALB/c nude mice injected with HepG2 liver cancer cells at a dose of 200 mg/kg | ↓↓ tumor size ↑↑ lifespan with no or low systemic and pathological toxicity |
[132] |
Effects in female BALB/c mice injected with CT-16 colon cancer cells at a dose of 200 mg/kg | Inhibited proliferation Induced apoptosis No obvious change in body weight or histological morphology of normal organs after treatment |
[133] | ||||
Roots | China | Acetone | n.s. | Effects in male Foxn1 nu/nu mice injected with DBTRG-05MG human glioblastoma cells after 100 days of treatment at a dose of 200 mg/kg | Can penetrate the blood-brain barrier ↓↓ tumor size and the degree of neovascularization ↑↑ PCNA, VEGFR-1, and VEGFR-2 in 44.49%, 5.88%, and 5.85%, respectively, when compared to untreated control |
[135] |
Neuronal effects and anticataleptic activity | ||||||
In vitro assays | ||||||
Leaves | Turkey | Hydroethanolic (80% ethanol, v/v) |
var. alpina | Capacity to inhibit acetylcholinesterase activity | 10.38% inhibition at 50 µg/mL 24.30% inhibition at 100 µg/mL 32.89% inhibition at 200 µg/mL |
[61,107] |
Ripe Berries | Aqueous | 5.47% inhibition at 100 µg/mL 28.17% inhibition at 200 µg/mL |
||||
Shoots | Ethyl acetate, ethanolic, and acetone extracts | n.s. | 21.34% inhibition at 100 µg/mL (ethyl acetate extract) 13.46% inhibition at 100 µg/mL (ethanolic extract) 28.43% inhibition at 100 µg/mL (acetone extract) |
|||
Inhibitory percentages varying from 32.34 to 41.97%% inhibition at 100 µg/mL (ethyl acetate extract) Inhibitory percentages varying from 22.29 to 45.45% inhibition at 100 µg/mL (ethanolic extract) Inhibitory percentages varying from 1.91 to 38.55% inhibition at 100 µg/mL (acetone extract) | ||||||
Leaves | Ethyl acetate, ethanolic, and acetone extracts | n.s. | 20.02% inhibition at 100 µg/mL (ethyl acetate extract) 10.56% inhibition at 100 µg/mL (ethanolic extract) 32.34% inhibition at 100 µg/mL (acetone extract) |
|||
Ripe berries and leaves | Turkey | Aqueous | var. alpina | Capacity to inhibit butyrylcholinesterase activity | 25.87 (berries) and 25.33% (leaves) inhibition at 50 µg/mL 32.57 (berries) and 44.16% (leaves) inhibition at 100 µg/mL 36.97 (berries) and 62.01% (leaves) inhibition at 200 µg/mL |
[61,107] |
Hydroethanolic (80% ethanol, v/v) |
43.68 (berries) and 30.31% (leaves) inhibition at 50 µg/mL 45.19 (berries) and 33.17% (leaves) inhibition at 100 µg/mL 47.55 (berries) and 35.33% (leaves) inhibition at 200 µg/mL |
|||||
Unripe berries | Hydroethanolic (80% ethanol, v/v) |
44.17% inhibition at 50 µg/mL 48.96% inhibition at 100 µg/mL 49.95% inhibition at 200 µg/mL |
||||
In vivo assays | ||||||
Leaves | n.s. | Methanolic | n.s. | Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg | ↑↑ locomotor activity ↓↓ motor dysfunctions, including catalepsy and muscle rigidity |
[19] |
Plant material | India | Methanolic | Effects on Wistar rats with induced catalepsy by reserpine 4 h after juniper treatment at a dose of 200 mg/kg | ↓↓ catalepsy activity | [34] | |
Romania | Essential oil | Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42) male Wistar rat model of Alzheimer’s disease after 21 days of treatment | ↑↑ working memory and reference memory errors within radial arm maze task ↓↓ spontaneous alternations percentage within Y-maze task |
[136] | ||
Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats | ↑↑ acetylcholinesterase, superoxide dismutase and catalase activities, and malondialdehyde and protein carbonyl levels ↓↓ glutathione peroxidase-specific activity and the total content of the reduced glutathione |
[85] | ||||
Hepatoprotective effects | ||||||
In vivo assays | ||||||
Leaves | India | Ethyl acetate | n.s. | Effects on Wistar albino rats with hepatic damage caused by paracetamol for 14 days at a dose of 200 mg/kg | ↓↓ alkaline phosphatase (−57.41%), direct bilirubin (−30.33%) and total bilirubin (−38.41%), serum alanine aminotransferase (−34.17%), and serum aspartate aminotransferase (−27.58%) when compared to the untreated group Hepatoprotective effects with rearrangement promotion of portal triads and central veins |
[65] |
Stems | n.s. | Petroleum ether, chloroform, and ethanol extracts | n.s. | Effects on rats with hepatic damage caused by carbon tetrachloride | Hepatoprotective activity | [30] |
Co-combination of berries from juniper and Solanum xanthocarpum | India | Ethanolic | n.s. | Effects on Wistar albino rats with liver toxicity induced by paracetamol and azithromycin for 14 days at a dose of 200 mg/kg | ↓↓ serum glutamate oxaloacetate transaminase (−65.4%), serum glutamate pyruvate transaminase (−59.3%), alkaline phosphatase (66.8%), total bilirubin (62.1%), and liver inflammation Promoting liver tissue’s normal architecture |
[3] |
Tyrosinase inhibitory activity | ||||||
In vitro assays | ||||||
Berries | Republic of Korea | Methanolic | n.s. | Capacity to inhibit tyrosinase activity | about 50% inhibition at 100 µg/mL | [137] |
Renal effects | ||||||
In vivo assay | ||||||
Berries | Croatia | Aqueous | n.s. | Daily intake of 10% aqueous infusion, 0.1% of oil (with 0.2% Tween 20 solubilizer) by healthy female Wistar rats | ↑↑ diuresis and urine excretion without loss of electrolytes | [86] |
Antiurolithiasis effects | ||||||
In vitro assay | ||||||
Berries | Iran | Hydroethanolic (50% ethanol, v/v) |
n.s. | Capacity to dissolve urinary stone brought out from human kidney at concentrations of 500, 1000, and 2000 µg/mL | Dissolve urinary stones ↓↓ dry powder weight of stones ↑↑ the ratio of calcium oxalate in normal saline aqueous solution plus stone |
[138] |
Gastrointestinal effects | ||||||
In vivo assays | ||||||
Leaves | India | Methanolic (80% methanol, v/v) |
n.s. | Effects on adult male Wistar albino rats with ulcers induced by aspirin, serotonin, indomethacin, alcohol, and stress at doses of 50 and 100 mg/kg | ↓↓ aspirin, serotonin, indomethacin, alcohol, and stress-induced gastric ulcerations in rats ↑↑ healing rate of acetic acid-induced ulcers in rats |
[87] |
n.s. | Effects on pigs with histamine-induced duodenal lesions at doses of 50 and 100 mg/kg | ↓↓ histamine-induced duodenal lesions in pigs | ||||
Vessels and trachea protective effects in passive smoking | ||||||
In vitro assays | ||||||
Berries | Romania | Aerosols | n.s. | Effects of 3-week juniper aerosols (40 min/day) on female Sprague-Dawley rats firstly exposed to daily passive smoking for 6 weeks | ↓↓ acetylcholine endothelial-dependent relaxation | [139] |
Oil | n.s. | Effects of 3-week juniper nebulization (20 min/day) on the respiratory tract of rats which firstly exposed to 2 cigarettes per day, 5 days a week for 6 weeks | Bronchodilator effects mediated by nitric oxide | [140] | ||
Genotoxicity protective effects | ||||||
In vitro assays | ||||||
Berries | Romania | Hydroethanolic (50% ethanol, v/v) |
n.s. | Capacity to exhibit genoprotective effects against aberrations and abnormalities induced by ethanol on root-tip cells of Allium cepa L. | Can effectively protect chromosomes aberrations | [40] |
n.s.: not specified; IC50: half-maximal inhibitory concentration ↑↑: increase; ↓↓: reduction.
4.1. Antimicrobial, Antifungal, and Antiparasitic Potential
Antimicrobial and antiparasitic activity can be divided according to the nature of the employed extract, i.e., essential oils and phenolic-rich extracts, which in turn influence the different target activity, use, application, and range of microorganisms and parasitics inhibited [35] (Table 2). The use of essential oils is widespread in ethnobotanical phytotherapy, and for this reason, several works can be found [46]. Filipowicz et al. [89] analyzed the antibiotic capacity of different essential oils extracted from J. communis berries, each one with a specific composition. They concluded that the extract with a more balanced composition in its components (α-pinene, β-pinene, p-cymeno or limonene, among others) showed greater antibiotic effects against multiresistant hospital isolates belonging to the species Staphyllococcus aureus, Serratia marcescens, Enterobacter cloace, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumanii, and Listeria monocytogenes, as well as in Candida albicans. The authors also verified that there effectively existed a synergistic effect between all components of the oil.
On the other hand, essential oils from J. communis needles (var. alpina) are shown to have notable effects in inhibiting the growth of numerous dermatophyte fungi (Epidermophyton floccosum, Microsporum canis, M. gypseum, Trichophyton mentagrophytes, T. mentagrophytes var. interdigitale, T. rubrum, and T. verrucosum), with active concentrations ranging between 0.32 to 2.5 µL/mL (vs. inhibition values of 16 and 128 µg/µL for the antifungal fluconazole) [90]. However, essential oils of leaves and fruits of J. communis (var. communis) from Sardinia exhibited weak antibiotic activity against C. albicans, S. aureus, and P. aeruginosa (Minimum Inhibitory Concentrations (MICs) higher than 1 mg/mL) [91]. Even so, it was observed that the use of pure solutions of juniper essential oils showed lower activity than the solutions diluted in at least 50% ethanol; this evidence is probably due to an improvement in the solubility of essential oils, which in turn increase its effectiveness [36].
These results agree with those obtained in Slovenia using distillates obtained through medium-scale industrial processes. Here, the essential oils of J. communis were able to inhibit the development of S. aureus and C. albicans, both of type strains and clinical isolates, showing in the latter case inhibition halos of 7.00 ± 0.01 mm and 21.33 ± 0.88 mm, respectively [92].
Furthermore, the use of essential oils obtained from J. communis biomass, without differentiating each of its parts, showed remarkable inhibitory activity against Escherichia (E.) coli, at concentrations between 1.25 and 2.5 mg/mL. As expected, there were observed variations regarding the obtained data due to the different collection sites and consequent different edaphoclimatic conditions, which in turn influenced the essential oil extracts’ composition [75]. On the other hand, no notable inhibitory activities were observed against other Gram-negative bacteria, such as Proteus mirabilis, K. pneumoniae, P. aeruginosa, and Morganella morganii; however, a slight activity against L. monocytogenes and methicillin-resistant S. aureus was observed [75]. Similar results were obtained comparing the activity of commercial J. communis berry essential oils and hydrodistilled berry extracts from wild Portuguese plants, observing a considerable variation in the MIC, minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC). The obtained data were expressed in % v/v between each of the extracts, and even without showing susceptibility to the highest concentrations tested (2.5% v/v), greater susceptibility was seen to Gram-positive species (B. cereus, B. subtilis and S. aureus) than Gram-negative species [81]. The study of the antibiotic capacity of the essential oils of J. communis leaves against 16 species of bacteria and 14 species of fungi, some of them dermatophytes fungus, showed similar results to those already observed for bacteria, where Gram-positive ones had a greater susceptibility than Gram-negative ones, with MIC and MBC varying between 8 and 70% v/v. The MIC results observed for fungi ranged between 0.39 and 10% v/v, while MBC values were between 0.78 and 12.5% v/v [26]. The essential oils from J. communis fruits (var. alpina) showed an outstanding activity against different types of pathogenic fungi, with MIC values ranging between 1.25 and 20 µL/mL; the highest susceptibilities were found against dermatophyte fungi, such as M. canis, T. rubrum, or E. floccosum [84]. These results are similar to those obtained with essential oils of J. communis, with MIC values of 11.11 mg/mL and 13.98 mg/mL for different Aspergillus species and between 11.11 mg/mL and 12.50 mg/mL for species of the genus Penicillium, which are also 2 times higher than those obtained for the commercial antifungal ketoconazole [93].
The analysis of the volatile fraction of J. communis essential oils presented similar results to those observed in essential oils and phenolic-rich extracts, with an intense activity against Gram-positive bacteria such as S. aureus, but not against Gram-negative ones such as E. coli. In fact, a concentration about 3 times lower was necessary to inhibit S. aureus growth (4.75 µg/mL) compared to E. coli (16.8 µg/mL). The comparison between the volatile composition and other constituents of the Juniperus genus showed that there may exist a relationship between the quantity of sesquiterpene hydrocarbons and aromatic oxygenated hydrocarbons, mostly found in the extract of J. communis, and their effectiveness against Gram-positive bacteria [94]. Even so, the use of the volatile fraction extracted from berries of var. alpina, mainly composed of α-pinene and δ-3-carene, showed a lower MIC than the complete extract, at concentrations ranging from 0.16 to 1.25 µL/mL [84]. In this regard, it has been described that the antibiotic capacity of α-pinene depends on the enantiomeric properties of this compound, cultivation origin, and part of the plant (leaves or cones) [95].
In another way, the use of subinhibitory concentrations (1 mg/mL) of juniper-fruit essential oils has been shown to possess a severe effect as an antiadhesion agent in Campylobacter jelunni, preventing the formation of biofilms by up to 100% to concerning the control on plastic surfaces [96]. The use of essential oils of J. communis from the whole plant (leaves and branches) has been shown to have a temperature-dependent growth-inhibitory effect (MIC) for bacteria of the genus Mycobacterium, at concentrations between 0.8 and 3.2 mg/mL. Although the use of subinhibitory concentrations allows limiting the formation of biofilms by up to 49% after 3 days [98], its combination with essential oils extracted from Helichrysum italicum has been shown to have synergistic activity, allowing the concentrations used to be reduced 3-fold to achieve similar effects [97]. It has also been observed that the use of essential oils from J. communis berries is capable of reducing the adhesion of L. monocytogenes cells to HT-29 and HCT116 colon-cancer cells by 62%, thus reducing the capacity of this foodborne pathogen to cause intracellular infections by establishing favorable and competent unions with the host cells [93].
Comparing a total of 72 different plants used in European ethnobotany, the hexane extract of J. communis leaves was one of the most effective in inhibiting pathogenic microorganisms present in the oral microbiota, with higher inhibition halos in diffusion-inhibition tests and a greater range of inhibited microorganisms [99]. On the other hand, the ethanolic extract rich in phenolic compounds from J. communis seeds showed a discrete antibiotic activity, with inhibition halos ranging between 7 and 12 mm at solutions of 100 mg/mL dw, presenting a higher sensitivity against Gram-positive (S. epidermidis, S. aureus, B. subtilis) than Gram-negative (P. aeruginosa, E. coli) and fungal (C. albicans) strains. These data were supported by the obtaining MIC, yielding a result of 3.125 µg/mL for the three Gram-positive species when compared to values that varied between 12.5 µg/mL and 50 µg/mL regarding the other studied species [100]. The comparison between methanolic and aqueous phenolic-rich extracts from leaves of two different J. communis varieties (var. communis and var. saxatilis) revealed that the methanolic extract presents a higher activity, requiring lower concentrations to inhibit the growth of S. aureus (78.12 µg/mL and 39.06 µg/mL, respectively) when compared to the aqueous extracts, which required much higher concentrations (1250 µg/mL and 312.5 µg/mL respectively). Additionally, it was observed that the var. saxatilis was more active than var. communis [101]. Additionally, berries’ phenolic extracts from var. communis and var. saxatilis showed that although the var. communis had a higher concentration of phenolic compounds, the MIC and MBL were lower for the var. saxatilis against S. aureus (156.25 µg/mL), S epidermidis (1250 µg/mL), Enterococcus hirae (156.25 µg/mL), and B. subtilis (156.25 µg/mL), compared with var. communis (S. aureus (156.25 µg/mL), S epidermidis (1250 µg/mL), En. hirae (625 µg/mL), and B. subtilis (321.5 µg/mL) [70]. On the other hand, the use of aqueous extract rich in phenolics against different bacteria and fungi showed around 50% more activity in disk-inhibition tests against Gram-positive bacteria (Lactobacillus fermentum—17 mm, S. aureus—15 mm and L. monocytogenes—15 mm) than against Gram-negative (P. aeruginosa—10 mm and Acinetobacter baumannii—11 mm). In the case of fungi, very discrete inhibition activities were observed (C. utilis—3 mm, Aspergillus sp.—6 mm and Fusarium sp.—2 mm) [102].
Another possibility is the combination of these extracts rich in phenolic compounds with routinely used commercial antibiotics such as tetracycline, chloramphenicol, and erythromycin. It was already reported that their combination with alcoholic extracts rich in phenolic compounds from J. communis leaves can effectively improve their efficiency against E. coli, S aureus, and K. pneumoniae by between 2 and 525 times, allowing a considerable reduction in the MIC of the antibiotic [104].
The use of subinhibitory concentrations (1 mg/mL) of ethanolic extracts and essential oils of juniper berries can also have a severe effect as an antiadhesion agent in Campylobacter jeunni, preventing the formation of biofilms by up to 95% on plastic surfaces [96]. In this way, the use of methanolic and aqueous extracts of J. communis var. communis and var. saxatilis branches can inhibit the growth of S. aureus. The methanolic extract showed reductions in initial adhesion after 3 h (22% in var. saxatilis and 44% in var. communis) and in the formation of biofilms 24 h after inoculation (66% in var. saxatilis and 68% in var. communis). Meanwhile, the aqueous extract proved to be more active in controlling biofilm formation, limiting the initial adhesion of bacterial cells to surfaces (25% in var. communis and 50% in var. saxatilis) and the extent of the biofilm formed (81% in var. communis and 84% in var. saxatilis) [103].
Concerning antiparasitic potential, essential oils extracted from leaves and stems of J. communis showed potential to inhibit the growth of two malarial strains different to Plasmodium falciparum, which were chloroquine-resistant (FcBl) and chloroquine-sensitive (Nigerian) strains, exhibiting in both cases an IC50 value of 1 mg/mL after 24 and 72 h of exposure. No cumulative effects were found over time [105]. This activity is mainly due to the presence of α-pinene, which is one of the main essential oils extracted from this plant. In fact, this terpene has already been shown to possess notable antimalarial activity (IC50 value of 1.2 µM) [106].
4.2. Antioxidant Activity
The antioxidant power of J. communis was established using different in vitro antioxidant assays, such as 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), superoxide anion and hydroxyl radical scavenging assays, and metal-chelating potential, as well as by in vivo assays (Table 3).
4.2.1. In Vitro Studies
Focusing on in vitro tests, and concerning the DPPPH●, the ethanolic extract of berries showed a half-maximal inhibitory concentration (IC50) of 1.42 µg/mL [40]. Additionally, its ethanol, ethyl acetate, and chloroform extracts revealed IC50 values of 28.55, 106.44, and 257.66 µg/mL, respectively [50]. Berries’ methanolic extracts and their essential oils also exhibited the capacity to scavenge DPPH● (IC50 varying between 6.86 and 13.66 µg/L, and from 1.27 to 4.25 µg/L, respectively), ferric species (reducing power ranging 6.90 and 10.70 mM FeSO4·7H2O for the methanolic extract and between 0.47 and 1.11 mM FeSO4·7H2O for the essential oil), and β-carotene species (24.36–30.63% for the methanolic extract and 1.19–2.39% concerning the essential oil) [63]. Berries’ ethanolic extracts also reveal the capacity to scavenge hydroxyl radicals, showing inhibitory values ranging from 65.59 to 88.12% for crushed and between 15.52 and 32.85% for noncrushed berries [67]. Ethanolic extracts of J. communis berries also revealed the ability to scavenge peroxyl radicals (3876 µM Trolox equivalents at a concentration of 1 mg/mL) [69] and reduce power potential (12.82 ascorbic acid equivalent/mL) [70], while its essential oil can scavenge ABTS•+ species (IC50 value of 10.96 µg/mL) and superoxide anions (IC50 of 0.822 µg/mL), and remove hydroxyl radicals before they can degrade deoxyribose (IC50 = 0.0066 µg/mL) [32]. Ethanolic, aqueous, and ethyl acetate fractions of J. communis leaves can also reduce DPPH● (IC50 values of 213, 347, and 177 µg/mL, respectively) [65], while its methanolic extracts showed an IC50 value of 258 µg/mL [60]. On the other hand, their ethanolic and ethyl acetate fractions can chelate ferric species (IC50 scores of 654 and 261 µg/mL, respectively) [65]. Acetate extracts revealed the potential to chelate metals, displaying an inhibitory effect of 6.05% at 1 mg/mL [107]. Ethanolic leaf extracts also showed the capacity to capture superoxide anions at concentrations of 0.5, 1 and 2 mg/mL, revealing inhibitory percentages of 20.26, 25.00 and 25.38%, respectively [61]. In addition, their distilled extracts and essential oils showed lipid-peroxidation inhibitory potential (IC50 values of 540 and 2440 µg/mL, respectively), while distilled extracts showed a ferric reduction activity of 78.77 mg of ascorbic acid equivalents per g of dw [71]. Essential oils of its leaves revealed an IC50 score of 660 µg/mL regarding the capture of DPPH● [79]. In the ABTS●+ assay; hydroethanolic extracts of its leaves and fruits revealed inhibitory percentages of 99.5 and 42.5%, respectively, at 3000 µg/mL [66].
On the other hand, J. communis shoots showed potential to reduce reactive oxygen species and increase the activity of intracellular antioxidant-enzyme superoxide dismutase and catalase [56]. Furthermore, its acetone, ethyl acetate, and ethanol extracts showed inhibitory percentages of 6.05, 22.59, and 12.31%, respectively, at 1 mg/mL regarding metal-chelating potential [107]. In addition, essential oils of its twigs can inhibit peroxy-radical-induced oxidation, exhibiting values of around 120 µmol Trolox/gram of essential oil [53]. Ethanolic extracts of hops also displayed ferric-ion-reducing antioxidant power (4.17 mg of ascorbic acid equivalents per g), and the capacity to capture DPPH● and ABTS●+ species (9.26 and 49.54 mg of ascorbic acid equivalents per g, respectively) [68].
4.2.2. In Vivo Studies
The administration of methanolic extracts of this plant (200 mg/kg) for 21 days on chlorpromazine-induced Parkinson’s disease in rats also showed increments in reduced glutathione and decreased levels of TBARS as compared to the untreated group [19]. Furthermore, the inhalation of its oil for 60 min daily for 21 days revealed higher levels of superoxide dismutase and catalase enzymes, and glutathione peroxidase activity on rats’ hippocampus subjected to amyloid β (1–42)-induced oxidative stress [85].
The remarkable antioxidant abilities showed by J. communis L. species are intimately linked to their phenolic and terpenoid content, in particular the presence of quercetin aglycone and their derivatives [32,67,69,71,79]. This flavan-3-ol possesses several hydroxyl groups in its constitution, which makes it a potent radical scavenger. As evidence, positive correlations (r > 0.80; p < 0.05) were already reported concerning their levels and capacity to neutralize DPPH● [108] and to inhibit lipid peroxidation in human erythrocytes [109,110]. Regarding terpenes’ antioxidant activity, Burits and colleagues [111] already reported that α-pinene, ρ-cymene, limonene, and linalool possess notable capacities to block lipid peroxidation (IC50 values of 0.51, 0.69 and 0.67 µL/mL, respectively) and to avoid deoxyribose degradation (IC50 scores of 0.78, 0.91 and 0.28 µL/mL, respectively). Similar potential was also reported by Emamia and collaborators [112] concerning β-pinene, cedrol, and sabinene antioxidant potential. Moreover, this property also depends on the extraction solvents applied, usually being higher when water–alcohol mixtures are used, given their great affinity for both lipophilic and hydrophilic bioactive molecules [50,59].
4.3. Anti-Inflammatory and Antinociceptive Properties
The anti-inflammatory effects of this plant have already been evaluated by in vitro and in vivo studies.
4.3.1. In Vitro Studies
By in vitro studies, it was already mentioned that aqueous extracts of J. communis can inhibit prostaglandins by 55% at 200 µg/mL and platelet-activating factor-induced exocytosis by 78% at 250 µg/mL [25]. Moreover, Schneider et al. [88] also revealed that methylene chloride extracts of its woods and berries, and berry ethyl acetate extract at 100 µg/mL can effectively reduce the production of 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 54.0, 66.2, and 76.2%, respectively. Essential oils of its plant material (twigs, leaves, and fruits) from two different Spanish regions also showed potential to inhibit the lipopolysaccharide-induced nitric oxide production on RAW 264.7 murine macrophage cells (IC50 values of 84.80 and 23.98 µg/mL for the regions of Almazán and Barriomartín, respectively) [75]. From the methylene chloride extract of the wood were extracted cryptojaponol and β-sitosterol, which in turn showed inhibitory activities of 55.4 and 25.0% regarding 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid production, respectively, at concentrations of 100 µg/mL.
4.3.2. In Vivo Studies
Focusing on in vivo studies, Mascolo and collaborators [113] screened the anti-inflammatory potential of hydroethanolic extracts of 27 plants from different families largely used in Italian folk medicine and reported that J. communis was one of the most effective in reducing the rats’ swelling-foot edema induced by carrageenin. Indeed, the obtained data revealed that at doses of 100 and 200 mg/kg and after 7 days of treatment, a reduction was verified regarding carrageenin-foot edema by 60% and 79%, respectively, against 45% shown by positive-control indomethacin (5 mg/kg). Similar results were reported by Akkol et al. [114]. Additionally, Akkol and coworkers [114] also verified that these extracts also revealed anti-inflammatory potential in PGE-2-induced hind-paw edema in a pattern similar as the carrageenin-edema model. More recently, the anti-inflammatory potential of J. communis was assessed using two different inflammation experimental models (dextran and kaolin), and it was verified through plethysmometry that the treatment with hydroethanolic microemulsions of J. communis berries can effectively reduce paw edema in the dextran-induced inflammation model, mainly due to its antihistaminic and antiserotonin activities. On the other hand, in the kaolin-induced inflammation model, the administration of this microemulsion showed potential to significantly downregulate the expression of proinflammatory interleukins (IL)-1β and IL-6, and tumor necrosis factor alfa, owing to its content in phenolics [40].
Beyond what was reported, Banerjee and colleagues [29] revealed that methanolic extracts of J. communis leaves possess analgesic effects. The authors conducted an in vivo study involving different nociceptive assays (acetic acid-induced writhing, formalin, and tail-flick tests) in rodents and verified that the extract administration of 100 mg/kg and 200 mg/kg can significantly inhibit, in a dose-dependent manner, the writhing response and the late phase related with the formalin test as compared to aspirin. Furthermore, it was also verified that this plant can act centrally, since the extract and pethidine effects were blocked by naloxone in the tail-flick test.
Nowadays, it is well-accepted that anti-inflammatory and antianalgesic activities of J. communis parts are intimately associated with the presence of phenolic compounds and terpenes, namely α-pinene, 1-octanol, amentoflavone, and linalool, whose capacity to inhibit inflammatory cytokine and prostaglandin expression was already known [40,115,116,117]. Particularly, hydroxybenzoic acids (25 µM), caffeic acid (10 µM), ρ-coumaric acid (50 µM), and quercetin (100 µM) already revealed the ability to interfere with inflammatory-related pathways and reduce proinflammatory markers [118,119,120,121,122]. Additionally, amentoflavone isolated from methanolic extracts of J. communis leaves was shown to be useful in controlling inflammation, by reducing joints’ rigidity and increasing locomotion after 35 days of treatment in rats with Freund’s adjuvant-induced arthritis at a dose of 40 mg/kg [123].
4.4. Antidiabetic, Antihypercholesterolemic, and Antihyperlipidemic Effects
4.4.1. In Vitro Studies
Hydroethanolic extracts of J. communis leaves and fruits already displayed, through in vitro assays, the ability to inhibit α-amylase (inhibitory scores of 29.8 (fruit) and 53.6% (leaf) at 3 mg/mL), and α-glucosidase (IC50 values of 4.4 and 84.3 µg/mL for fruit and leaf respectively) activities [66]. Moreover, the aqueous extracts of this plant at 50 g/L also showed the capacity to significantly decrease glucose diffusion by 6% when compared with the negative control [124].
4.4.2. In Vivo Studies
Concerning in vivo studies, the capacity of J. communis berries (at 1 g/400 mL) revealed the capability to avoid polydipsia and weight losses, and in this way retard the development of diabetes in streptozotocin mice, as reported by Swanston-Flatt and colleagues [125]. Furthermore, decoctions of J. communis berries orally administrated at doses of 250 and 500 mg/kg showed potential to reduce hypoglycemia in normoglycemic rats, reduce blood glucose levels and mortality index, and prevent weight loss in streptozotocin-diabetic rats after 24 days of treatment at a dose of 125 mg/kg [126]. In addition, Banerjee and colleagues [31] verified that the oral administration of J. communis methanolic extracts (100 and 200 mg/kg) can effectively reduce blood glucose levels, total cholesterol, triglycerides, low-density lipoprotein, and very-low-density lipoprotein cholesterols, and increase high-density lipoprotein cholesterol in streptozotocin-nicotinamide-induced diabetic rats in a dose-dependent manner after 21 days of treatment.
Finally, a herbal preparation from Croatia composed of natural plants, including J. communis, also revealed the capacity to reduce glucose and fructosamine levels in alloxan-induced nonobese diabetic mice at 20 mg/kg after a 7-day treatment [127].
In addition to the mentioned, Akdogan and collaborators [33] conducted a one-month in vivo trial based on the daily administration of J. communis berry oil (dissolved in 0.5% of sodium carboxymethyl cellulose) in albino Wistar rats and verified that this berry showed potential to reduce cholesterol at concentrations of 50, 100, and 200 mg/kg. Particularly, the highest dose significantly increased blood-urea nitrogen and creatinine levels and reduced total cholesterol, oxidized low-density lipoprotein, alanine aminotransferase, and aspartate transaminase levels by 16%, 24%, 8.2%, and 10% when compared to the untreated cholesterol group. No anaemic effects or distinct morphological changes in rat kidneys were observed.
Briefly, these effects are mainly attributed to the capacity of J. communis to interfere with carbohydrate enzymes, increase peripheral glucose consumption, and protect pancreatic β-cells from damage [66,126].
4.5. Antiproliferative Effects
Considering the crescent incidence of cancer, it is not surprising that several different efforts are being conducted to discover new approaches and alternatives useful to reduce the development and/or to act as a complementary treatment against this malignancy [141]. Among plants, J. communis species have been intensively studied [71,73].
4.5.1. In Vitro Studies
Until now, this plant has already shown the in vitro capacity to suppress the growth of many cancer cells. For example, Lee and colleagues [128] revealed that berry extracts can induce apoptosis on OECM-1 human gingival squamous cancer cells, exhibiting an IC50 value of 46.20 µg/mL after 24 h of exposure. Furthermore, it was also reported that this plant can interfere with the growth of CE81T/VGH human esophageal squamous carcinoma (IC50 scores of 68.41, 64.33, and 60.07 µg/mL after 24, 48, and 72 h of exposure, respectively) and CE48T/VGH human esophageal epidermoid carcinoma cells (IC50 values of 69.38, 56.96, and 36.10 µg/mL after 24, 48, and 72 h of exposure, respectively), mainly by inducing cell-cycle arrest at the G0/G1 phase [39]. Methanolic extracts of its leaves also showed capacity to block the growth and development of C6 rat-brain tumor and HeLa human-cervix carcinoma cells (IC50 values of 28.43 and 32.96 µg/mL, respectively) [72], PC3 human-prostate cancer cells (IC50 = 23.8 µg/mL), HCT 116 human-colon cancer cells (IC50 = 37.6 µg/mL), and MCF7 breast cancer cells (IC50 = 23.8 µg/mL) after 24 h of exposure [129]. On the other hand, aqueous berry extracts can decrease the growth and invasion of MCF-7/AZ breast cancer cells (IC50 value of 50 µg/mL after 24 h of treatment) [130]. In addition to the mentioned, Fernandez and coworkers [131] also reported that methanolic extracts of its berries can block the proliferation of Caco-2 human colorectal and HeLa cervical cancer cells, showing IC50 values of 1383 and 2592 µg/mL, respectively, after 12 h of exposure. Their aqueous extracts also showed potential to inhibit both cancer cells after 12 h, exhibiting IC50 scores of 1516 (Caco-2 cancer cells) and 2157 µg/mL (HeLa cancer cells) [131]. On the other hand, essential oil and distilled extracts from J. communis berries revealed the potential to suppress A549 human lung adenocarcinoma epithelial-cell growth and development, revealing IC50 values of 69.4 and 1270 µg/mL, respectively, after 24 h of treatment [71]. Additionally, they also showed the ability to suppress the development of SH-SY5Y human neuroblastoma cells after 24 h of exposure (IC50 score of 53.7 µg/mL), which is evidence that this plant can penetrate the blood–brain barrier [134,135,142]. The capacity of J. communis plant material (twigs, leaves and berries) to suppress NCI-H460 lung carcinoma, MCF-7, AGS gastric carcinoma, and Caco-2 cell growth was also evaluated, revealing IC50 values varying depending on the origin [75]. Essential oil and distilled extracts of seed cones from J. communis also reveal the capacity to inhibit the growth of HT-29 (IC50 values of 125 and 625 µg/mL for essential oil and distilled extracts, respectively) and HCT116 cancer cells (IC50 values of 62.5 and 1250 µg/mL for essential oil and distilled extracts, respectively) after 24 h of exposure [93].
J. communis distilled extracts also seem to be useful in the prevention of melanoma tumorigenesis, since they already show potential to block B16/F10 melanoma cells growth, displaying IC50 values of 27 and 44 µg/mL after 24 and 48 h of exposure, respectively [73]. These data are in agreement with in vivo results [73]. Furthermore, this plant also showed potential to inhibit HepG2, Mahlavu, and J5 human hepatocellular carcinoma cell growth, in a dose- and time-dependent manner, revealing IC50 values of 43.9 µg/mL for HepG2 cells, 59.4 µg/mL for Mahlavu cells, and 53.2 µg/mL for J5 cells after 72 h of treatment [132].
4.5.2. In Vivo Studies
The administration of J. communis distilled extracts (200 mg/kg) for 23 days C57BL/6 mice showed the capacity to reduce tumor size by 45.2% when compared to the untreated group. It was also verified that J. communis treatment resulted in cell-cycle arrest at the G0/G1 phase; lower concentrations of B-cell lymphoma-2 (Bcl-2), procaspases 8 and 9; and higher levels of Bcl-2-associated X protein, apoptosis-inducing factor, cell-surface death receptor Fas, and Fas ligand [73]. On the other hand, the administration of J. communis essential oils (200 mg/kg) in BALB/c nude mice injected with HepG2 cancer cells showed the capacity to reduce tumor growth and extend the lifespan with no or low systemic and pathological toxicity [132]. Similar information was reported by Lai and colleagues [133] and Tsai and collaborators [135] regarding the antitumor effects of this plant against human colorectal adenocarcinoma and glioblastoma.
Remarkably, the antiproliferative and cytotoxic effects shown by this plant are mainly attributed to the capacity of phenolic compounds and terpenes to interact, in different ways, with cell-signaling pathways and cascades, inducing apoptosis and interfering with cell cycle progression [71,73,132,142]. Particularly, imbricatolic acid isolated from the methanolic extract of J. communis fresh ripe berries showed the ability to prevent cell-cycle progression in p53-null human lung cancer Calu-6 cells by inducing the upregulation of cyclin-dependent kinase inhibitors and their accumulation in the G1 phase of the cell cycle, as well as the degradation of cyclins A, D1, and E1 [143]. On the other hand, isocupressic acid and deoxypodophyllotoxin isolated from this plant can induce caspase-dependent apoptosis in malignant MB231 breast cancer cells; additionally, deoxypodophyllotoxin also showed the potential to inhibit cell-survival pathways mediated by MAPK/ERK and NFκB-signaling pathways [144].
4.6. Neuronal Effects and Anticataleptic Activity
J. communis parts also show great potential to working memory, and inhibit the activity of some enzymes associated with the progression of neurological pathologies, such as Alzheimer’s and Parkinson’s disease [19,61,85].
4.6.1. In Vitro Studies
Focusing on in vitro assays, acetylcholinesterase inhibitory percentages ranging from 5.47% (leaf hydroethanolic extracts at concentration of 100 µg/mL) to 32.89% (berries aqueous extracts at 200 µg/mL) were reported. Additionally, and regarding the inhibition of butyrylcholinesterase, scores ranging between 25.33% and 62.01% for leaf aqueous extracts at concentrations of 50 and 200 µg/mL were reported, and from 25.87% to 49.95% regarding aqueous extracts of its ripe berries at the same concentrations mentioned above [61]. Furthermore, ethyl acetate and ethanolic extracts of its shoots revealed the ability to inhibit both enzymes at a concentration of 100 µg/mL (inhibitory percentages of 20.02 and 21.34% for ethyl acetate extract regarding acetylcholinesterase and butyrylcholinesterase inhibition, respectively, and 22.29 and 45.45% for acetylcholinesterase and butyrylcholinesterase inhibition for the ethanolic extract, respectively) [107].
4.6.2. In Vivo Studies
Regarding in vivo assays, Bais et al. [19] reported that the daily administration of 200 mg/kg (i.p.) of J. communis methanolic extracts for 21 days in rats with induced Parkinson’s disease by chlorpromazine can effectively decrease motor dysfunctions, including catalepsy and muscle rigidity, and increase locomotor activity when compared to the untreated group. The obtained results are in line with previous data, which showed that the daily injection of similar extract (200 mg/kg, i.p.) can significantly reduce the retention on bar (catalepsy activity) by 75% in rats with induced catalepsy by reserpine [34]. In addition to the mentioned, the daily inhalation of 1% and 3% for 60 min during 21 days of juniper volatile oils extracted from J. communis, mainly composed of α-pinene, sabinene, myrcene, limonene, terpinen-4-ol, and α-thujene, by rats with induced Alzheimer’s disease, showed increases in working and long-term memories and decreases in acetylcholinesterase activity [85,136].
4.7. Hepatoprotective Effects
In Vivo Studies
Ethyl acetate fractions of leaves from J. communis have already been shown to be promising hepatoprotective agents. Rats with hepatic damage caused by paracetamol who ingested these fractions (200 mg/kg body weight) over two weeks showed lower levels of alkaline phosphatase (−57.41%), direct bilirubin (−30.33%) and total bilirubin (−38.41%), serum alanine aminotransferase (−34.17%), and serum aspartate aminotransferase (−27.58%) than the untreated group. Histopathological observations also proved the hepatoprotective effects of these leaves, promoting favorable portal triads and central-vein rearrangements [65]. Using a carbon tetrachloride-induced hepatic damage model, Mavin and Garg [30] revealed similar effects of J. communis stems. Furthermore, Singh et al. [145] reported that the daily ingestion of a combination of ethanolic berry extract of Solanum xanthocarpum (200 mg/kg) and J. communis (200 mg/kg) for 14 days can significantly attenuate liver toxicity induced by paracetamol and azithromycin in Wistar albino rats. In fact, the administration of both showed a capability to reduce altered biochemical parameters, including serum glutamate oxaloacetate transaminase (−65.4%), serum glutamate pyruvate transaminase (−59.3%), alkaline phosphatase (66.8%), and total bilirubin (62.1%), and reverse histopathological alterations, by promoting the liver tissue’s normal architecture and diminishing liver inflammation.
4.8. Tyrosinase Inhibitory Activity
In Vitro Studies
Methanolic extracts of berries from J. communis already showed the capacity to suppress mushroom tyrosine activity by about 50% at concentrations of 100 µg/mL. This data is very promising and can be considered an indicator regarding the potential of this plant to treat skin disorders, since this enzyme is closely involved in the production of melanin. Moreover, some compounds isolated from them also showed similar potential, namely hypolaetin 7-O-β-xylopyranoside, which exhibited an IC50 value of 45.15 µM, and kojic acid (IC50 score of 25.03 µM) [137].
4.9. Renal and Antiurolithiasis Effects
4.9.1. In Vitro Studies
Relative to antiurolithiasis properties, J. communis berries at concentrations of 500, 1000, and 2000 µg/mL solutions showed potential to dissolve urinary stones brought out from the human kidney, causing reductions of 50, 20, 10, and 20% in urinary stones composed of calcium oxalate, calcium hydrogen phosphate, magnesium ammonium phosphate, and ammonium urate, respectively. The dry-powder weight of stones in normal saline also decreased from 1458 to 1162, 1124, 1136, 1144, 1096, 1126, and 1130 mg after exposure to increasing Juniperus berry concentrations. Furthermore, it was also observed that the ratio of calcium oxalate in normal saline aqueous solution plus stone increased from 70% to 80% after using some fractions of J. communis berry extracts [138].
4.9.2. In Vivo Studies
Different parts of J. communis plants have been largely used since ancient times to treat renal disorders because of their diuretic and urinary antiseptic effects. Indeed, Stanic et al. [86] reported that the daily intake of 10% aqueous infusion, 0.1% of oil (with 0.2% Tween 20 solubilizer) from juniper berries, and 0.01% of terpinen-4-ol (one of the main components of Juniperus plants) in rats at 5 mL/100 g can effectively stimulate diuresis from day 2, increasing urine excretion without loss of electrolytes. Between them, the infusion showed the most prominent diuretic activity (+43% on day two and 44% on day three), which proves that the diuretic activity of juniper berries is due to the combination of essential oil and hydrophilic components, which together can increase the glomerular filtration rate. Even so, recent studies use do not recommend their continuous use due to the presence of terpinen-4-ol, which has already been shown to promote kidney irritation [146].
4.10. Gastrointestinal Effects
In Vivo Studies
Pramanik and colleagues [87] reported that J. communis leaves can be useful in ameliorating some gastrointestinal ailments. The authors verified that the intraperitoneal administration of the methanolic extract at doses of 50 and 100 mg/kg can effectively inhibit aspirin, serotonin, indomethacin, alcohol, and stress-induced gastric ulcerations in rats, and histamine-induced duodenal lesions in guinea pigs. The treatment with the leaf extract also enhanced the healing rate of acetic acid-induced ulcers in rats. Additionally, the analysis of gastric juice revealed that although the leaf extract did not alter its pH or its peptic activity, this one managed to significantly diminish its volume and total acidity. These benefits shown by J. communis parts are positively linked to their anti-inflammatory and analgesic properties.
4.11. Vessels and Trachea Protective Effects in Passive Smoking
In Vivo Studies
The capacity of J. communis aerosols to reverse the vasomotor impairment associated with passive exposure to cigarette smoke was also evaluated in female Sprague Dawley rats. Animals were first exposed to daily passive smoking for 6 weeks. In the last 15 days of the study, one of the groups was also subject to a daily administration of J. communis oil aerosols for 40 min/day. In the end, thoracic aortas were harvested and analyzed, and it was possible to verify that the use of aerosols can significantly reduce acetylcholine endothelial-dependent relaxation [139]. Furthermore, Pleşa and colleagues [140] reported that the nebulization with J. communis berry oil (20 min/day per 3 weeks) exerts bronchodilator effects mediated by nitric oxide in the respiratory tract of rats exposed to 2 cigarettes per day, 5 days a week for 6 weeks. This activity is closely linked to the antioxidant effects shown by this plant. Even so, the authors also verified that this aerosol exposure can cause moderate irritation and inflammation along the tracheobronchial tract in nonsmoker rats.
4.12. Genotoxicity Protective Effects
In Vitro Studies
Recently, J. communis berries displayed capacity to inhibit chromosome aberrations and mitotic abnormalities induced by ethanol on Allium cepa L. root-tip cells, with these properties being intimately linked to their capacity to scavenge radicals and reduce oxidative stress levels [40].
4.13. Toxicity Effects
4.13.1. In Vitro Acute Toxicity
Fernandez and colleagues [131] assessed the toxicity of methanolic and aqueous berry extracts of J. communis through Artemia franciscana nauplii lethality assay, and proved their safety once the obtained IC50 values were higher than 1 mg/mL. Additionally, the toxicity and undesirable side effects of J. communis were evaluated in albino rats based on the oral administration of ethyl acetate fractions of their leaves for 2 weeks. The obtained data revealed no mortality nor any negative change in physiological parameters and appearance until the dose of 2 g/kg [65].
4.13.2. Antiprogestogenic and Abortifacient In Vivo Effects
Pathak and colleagues [147] reported that hydroethanolic extracts (90% ethanol, v/v) of J. communis berries did not show estrogenic nor antiestrogenic effects, but displayed antiprogestational and antifertility activity at doses ranging from 50–450 mg/kg on female rats. In another study, Agrawal et al. [148] found that the oral administration of hydroethanolic extracts (50% ethanol, v/v) from J. communis berries at doses of 300 and 500 mg/kg in albino female rats from day 1 to day 7 of pregnancy exhibited dose-dependent anti-implantation activity. Furthermore, the authors also reported that these extracts at the same concentrations promoted abortifacient effects when administrated on days 14, 15, and 16 of pregnancy. Still, no evidence of teratogenicity effects was found.
5. Conclusions
The pharmacological effects of the zimbro plant have been known since ancient times, and are mainly attributed to the high concentration of phenolic compounds, in particular the presence of 5-O-caffeoylquinic and quinic acids, catechin, epicatechin, amentoflavone, quercetin, luteolin, apigenin, and naringenin; and VOCs, namely monoterpenes and sesquiterpenoids. In fact, these phytochemicals confer remarkable biological activities, such as important antimicrobial capacity, the ability to modulate biofilm formation, as well as notable antioxidant, hepatoprotective, anticancer, anti-inflammatory, antihypercholesterolemic, neuroprotective, and genotoxic effects. Given this, it is not surprising that its use and incorporation in dietary supplements, nutraceuticals, and pharmaceutical drugs is a hot topic among researchers, considering its potential to attenuate—or even treat—several diseases and ailments. However, more studies, namely clinical trials, are needed to fully explore and reveal all the biological potentials and optimal doses of this plant.
Author Contributions
A.C.G., J.D.F.-F. and L.R.S. performed the literature search and wrote the manuscript; P.C. and G.A. provided expert comments and revised it critically for important intellectual content. All authors have read and agreed to the published version of the manuscript.
Funding
This work was partially supported by CICS-UBI (UIDP/00709/2020) financed by National Funds from Fundação para a Ciência e a Tecnologia (FCT), Community Funds (UIDB/00709/2020) and CENTRO-04-3559-FSE-000162. The authors are grateful to the Foundation for Science and Technology (FCT), Ministry of Science, Technology and Higher Education (MCTES), European Social Fund (EFS) and European Union (EU) for the PhD fellowship of Ana C. Gonçalves (2020.04947.BD). José D. Flores-Félix was supported by European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101003373.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
All data are reported in the manuscript.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Gezici S., Şekeroğlu N. Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents. Anticancer Agents Med. Chem. 2019;19:101–111. doi: 10.2174/1871520619666181224121004. [DOI] [PubMed] [Google Scholar]
- 2.Benarba B., Pandiella A. Colorectal cancer and medicinal plants: Principle findings from recent studies. Biomed. Pharmacother. 2018;107:408–423. doi: 10.1016/j.biopha.2018.08.006. [DOI] [PubMed] [Google Scholar]
- 3.Sen T., Samanta S.K. Advances in Biochemical Engineering/Biotechnology. Volume 147. Springer; Berlin/Heidelberg, Germany: 2015. Medicinal plants, human health and biodiversity: A broad review; pp. 59–110. [DOI] [PubMed] [Google Scholar]
- 4.Dutra R.C., Campos M.M., Santos A.R.S., Calixto J.B. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives. Pharmacol. Res. 2016;112:4–29. doi: 10.1016/j.phrs.2016.01.021. [DOI] [PubMed] [Google Scholar]
- 5.Gholipour S., Sewell R.D.E., Lorigooini Z., Rafieian-Kopaei M. Medicinal plants and atherosclerosis: A review on molecular aspects. Curr. Pharm. Des. 2018;24:3123–3131. doi: 10.2174/1381612824666180911121525. [DOI] [PubMed] [Google Scholar]
- 6.Kirichenko T.V., Sukhorukov V.N., Markin A.M., Nikiforov N.G., Liu P.Y., Sobenin I.A., Tarasov V.V., Orekhov A.N., Aliev G. Medicinal plants as a potential and successful treatment option in the context of atherosclerosis. Front. Pharmacol. 2020;11:1–15. doi: 10.3389/fphar.2020.00403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Akkol K.E., Dereli T.G.F., Sobarzo-Sánchez E., Khan H. Roles of medicinal plants and constituents in gynecological cancer therapy: Current literature and future directions. Curr. Top. Med. Chem. 2020;20:1772–1790. doi: 10.2174/1568026620666200416084440. [DOI] [PubMed] [Google Scholar]
- 8.Singh G., Passari A.K., Momin M.D., Ravi S., Singh B.P., Kumar N.S. Ethnobotanical survey of medicinal plants used in the management of cancer and diabetes. J. Tradit. Chin. Med. 2020;40:1007–1017. doi: 10.19852/j.cnki.jtcm.2020.06.012. [DOI] [PubMed] [Google Scholar]
- 9.Naveed M., Majeed F., Taleb A., Zubair H.M., Shumzaid M., Farooq M.A., Baig M.M.F.A., Abbas M., Saeed M., Changxing L. A review of medicinal plants in cardiovascular disorders: Benefits and risks. Am. J. Chin. Med. 2020;48:259–286. doi: 10.1142/S0192415X20500147. [DOI] [PubMed] [Google Scholar]
- 10.Ajebli M., Eddouks M. Phytotherapy of hypertension: An updated overview. Endocr. Metab. Immune Disord. Drug Targets. 2020;20:812–839. doi: 10.2174/1871530320666191227104648. [DOI] [PubMed] [Google Scholar]
- 11.Shayganni E., Bahmani M., Asgary S., Rafieian-Kopaei M. Inflammaging and cardiovascular disease: Management by medicinal plants. Phytomedicine. 2016;23:1119–1126. doi: 10.1016/j.phymed.2015.11.004. [DOI] [PubMed] [Google Scholar]
- 12.Rouhi-Boroujeni H., Heidarian E., Rouhi-Boroujeni H., Deris F., Rafieian-Kopaei M. Medicinal plants with multiple effects on cardiovascular diseases: A systematic review. Curr. Pharm. Des. 2017;23:999–1015. doi: 10.2174/1381612822666161021160524. [DOI] [PubMed] [Google Scholar]
- 13.Unuofin J.O., Lebelo S.L. Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: An updated review. Oxid. Med. Cell. Longev. 2020:1356893. doi: 10.1155/2020/1356893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Salehi B., Ata A., Kumar N.V.A., Sharopov F., Ramírez-Alarcón K., Ruiz-Ortega A., Ayatollahi S.A., Fokou P.V.T., Kobarfard F., Zakaria Z.A., et al. Antidiabetic potential of medicinal plants and their active components. Biomolecules. 2019;9:551. doi: 10.3390/biom9100551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pathak- Gandhi N., Vaidya A.D.B. Management of Parkinson’s disease in Ayurveda: Medicinal plants and adjuvant measures. J. Ethnopharmacol. 2017;197:46–51. doi: 10.1016/j.jep.2016.08.020. [DOI] [PubMed] [Google Scholar]
- 16.Lemoine P., Bablon J.C., Da Silva C. A combination of melatonin, vitamin B6 and medicinal plants in the treatment of mild-to-moderate insomnia: A prospective pilot study. Complement. Ther. Med. 2019;45:104–108. doi: 10.1016/j.ctim.2019.05.024. [DOI] [PubMed] [Google Scholar]
- 17.Fejér J., Gruľová D., Eliašová A., Kron I., De Feo V. Influence of environmental factors on content and composition of essential oil from common Juniper ripe berry cones (Juniperus communis L.) Plant Biosyst. 2018;152:1227–1235. doi: 10.1080/11263504.2018.1435577. [DOI] [Google Scholar]
- 18.Pers-Kamczyc E., Tyrała-Wierucka Ż., Rabska M., Wrońska-Pilarek D., Kamczyc J. The higher availability of nutrients increases the production but decreases the quality of pollen grains in Juniperus communis L. J. Plant Physiol. 2020;248:153156. doi: 10.1016/j.jplph.2020.153156. [DOI] [PubMed] [Google Scholar]
- 19.Bais S., Gill N.S., Kumar N. Neuroprotective effect of Juniperus communis on chlorpromazine induced Parkinson disease in animal model. Chin. J. Biol. 2015;2015:542542. doi: 10.1155/2015/542542. [DOI] [Google Scholar]
- 20.Verheyen K., Adriaenssens S., Gruwez R., Michalczyk I.M., Ward L.K., Rosseel Y., Van den Broeck A., García D. Juniperus communis: Victim of the combined action of climate warming and nitrogen deposition? Plant Biol. 2009;11:49–59. doi: 10.1111/j.1438-8677.2009.00214.x. [DOI] [PubMed] [Google Scholar]
- 21.Meireles C., Pinto-Gomes C., Cano E. Approach to climatophilous vegetation series of Serra da Estrela (Portugal) Acta Bot. Gall. 2012;159:283–287. doi: 10.1080/12538078.2012.737147. [DOI] [Google Scholar]
- 22.Khare C.P. Indian Medicinal Plants. Springer; Berlin/Heidelberg, Germany: 2020. [Google Scholar]
- 23.Bais S., Gill N.S., Rana N., Shandil S. A phytopharmacological review on a medicinal plant: Juniperus communis. Int. Sch. Res. Not. 2014;2014:634723. doi: 10.1155/2014/634723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Modnicki D., Łabędzka J. Estimation of the total phenolic compounds in juniper sprouts (Juniperus communis L., Cupressaceae) from different places at the kujawsko-pomorskie province. Herba Pol. 2009;55:127–132. [Google Scholar]
- 25.Tunón H., Olavsdotter C., Bohlin L. Evaluation of anti-inflammatory activity of some Swedish medicinal plants. Inhibition of prostaglandin biosynthesis and PAF-induced exocytosis. J. Ethnopharmacol. 1995;48:61–76. doi: 10.1016/0378-8741(95)01285-L. [DOI] [PubMed] [Google Scholar]
- 26.Pepeljnjak S., Kosalec I., Kalodera Z., Blažević N. Antimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae) Acta Pharm. 2005;55:417–422. [PubMed] [Google Scholar]
- 27.Abbassy M.A., Marei G.I.K. Antifungal and chemical composition of essential oils of Juniperus communis L. and Thymus vulgaris L. against two phytopathogenic fungi. J. Appl. Sci. Res. 2013;9:4584–4588. [Google Scholar]
- 28.Sati S.C., Joshi S. Antibacterial potential of leaf extracts of Juniperus communis L. from Kumaun Himalaya. Afr. J. Microbiol. Res. 2010;4:1291–1294. [Google Scholar]
- 29.Banerjee S., Mukherjee A., Chatterjee T.K. Evaluation of analgesic activities of methanolic extract of medicinal plant Juniperus communis Linn. Int. J. Pharm. Pharm. Sci. 2012;4:547–550. [Google Scholar]
- 30.Mavin, Garg G.P. Screening and evaluation of pharmacognostic, phytochemical and hepatoprotective activity of J. communis L. stems. Int. J. Pharma Bio Sci. 2010;1 [Google Scholar]
- 31.Banerjee S., Singh H., Chatterjee T.K. Evaluation of anti-diabetic and anti-hyperlipidemic potential of methanolic extract of Juniperus communis (L.) in streptozotocinnicotinamide induced diabetic rats. Int. J. Pharma Bio Sci. 2013;4:10–17. [Google Scholar]
- 32.Höferl M., Stoilova I., Schmidt E., Wanner J., Jirovetz L., Trifonova D., Krastev L., Krastanov A. Chemical composition and antioxidant properties of juniper berry (Juniperus communis L.) essential oil. Action of the essential oil on the antioxidant protection of saccharomyces cerevisiae model organism. Antioxidants. 2014;3:81–98. doi: 10.3390/antiox3010081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Akdogan M., Koyu A., Ciris M., Yildiz K. Anti-hypercholesterolemic activity of Juniperus communis Lynn oil in rats: A biochemical and histopathological investigation. Biomed. Res. 2012;23:321–328. [Google Scholar]
- 34.Bais S., Gill N.S., Rana N. Effect of Juniperus communis extract on reserpine induced catalepsy. Inventi Impact Ethnopharmacol. 2014;2014:1–4. [Google Scholar]
- 35.Raina R., Verma P.K., Peshin R., Kour H. Potential of Juniperus communis L as a nutraceutical in human and veterinary medicine. Heliyon. 2019;5:e02376. doi: 10.1016/j.heliyon.2019.e02376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rezvani S., Rezai M.A., Mahmoodi N. Analysis and antimicrobial activity of the plant Juniperus communis. Rasayan J. Chem. 2009;2:257–260. [Google Scholar]
- 37.Ochocka J.R., Asztemborska M., Zook D.R., Sybilska D., Perez G., Ossicini L. Enantiomers of monoterpenic hydrocarbons in essential oils from Juniperus communis. Phytochemistry. 1997;44:869–873. doi: 10.1016/S0031-9422(96)00587-0. [DOI] [Google Scholar]
- 38.Laouar A., Klibet F., Bourogaa E., Benamara A., Boumendjel A., Chefrour A., Messarah M. Potential antioxidant properties and hepatoprotective effects of Juniperus phoenicea berries against CCl4 induced hepatic damage in rats. Asian Pac. J. Trop. Med. 2017;10:263–269. doi: 10.1016/j.apjtm.2017.03.005. [DOI] [PubMed] [Google Scholar]
- 39.Li C.Y., Lee S.C., Lai W.L., Chang K.F., Huang X.F., Hung P.Y., Lee C.P., Hsieh M.C., Tsai N.M. Cell cycle arrest and apoptosis induction by Juniperus communis extract in esophageal squamous cell carcinoma through activation of p53-induced apoptosis pathway. Food Sci. Nutr. 2021;9:1088–1098. doi: 10.1002/fsn3.2084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fierascu I., Ungureanu C., Avramescu S.M., Cimpeanu C., Georgescu M.I., Fierascu R.C., Ortan A., Sutan A.N., Anuta V., Zanfirescu A., et al. Genoprotective, antioxidant, antifungal and anti-inflammatory evaluation of hydroalcoholic extract of wild-growing Juniperus communis L. (Cupressaceae) native to Romanian southern sub-Carpathian hills. BMC Complement. Altern. Med. 2018;18:3. doi: 10.1186/s12906-017-2066-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.García D., Zamora R., Gómez J.M., Jordano P., Hódar J.A. Geographical variation in seed production, predation and abortion in Juniperus communis throughout its range in Europe. J. Ecol. 2000;88:436–446. doi: 10.1046/j.1365-2745.2000.00459.x. [DOI] [Google Scholar]
- 42.Castro M.R., Belo A.F., Afonso A., Zavattieri M.A. Micropropagation of Juniperus navicularis, an endemic and rare species from Portugal SW coast. Plant Growth Regul. 2011;65:223–230. doi: 10.1007/s10725-011-9590-1. [DOI] [Google Scholar]
- 43.Adams R.P., Murata J., Takahashi H., Schwarzbach A.E. Taxonomy and evolution of Junperus communis: Insight from DNA sequencing and SNPs. Phytologia. 2011;93:185–197. [Google Scholar]
- 44.Cano E., Musarella C.M., Cano-Ortiz A., Fuentes J.C.P., Torres A.R., González S.D.R., Gomes C.J.P., Quinto-Canas R., Spampinato G. Geobotanical study of the microforests of Juniperus oxycedrus subsp. badia in the central and Southern Iberian Peninsula. Sustainability. 2019;11:1111. doi: 10.3390/su11041111. [DOI] [Google Scholar]
- 45.Knyazeva S.G., Hantemirova E.V. Comparative analysis of genetic and morpho-anatomical variability of common Juniper (Juniperus communis L.) Russ. J. Genet. 2020;56:48–58. doi: 10.1134/S102279542001007X. [DOI] [Google Scholar]
- 46.Ložienė K., Rimantas Venskutonis P. Essential Oils in Food Preservation, Flavor and Safety. Academic Press; London, UK: 2016. Chapter 56—Juniper (Juniperus communis L.) oils. [DOI] [Google Scholar]
- 47.García D., Zamora R., Hódar J.A., Gómez J.M. Age structure of Juniperus communis L. in the Iberian Peninsula: Conservation of remnant populations in Mediterranean mountains. Biol. Conserv. 1999;87:215–220. doi: 10.1016/S0006-3207(98)00059-7. [DOI] [Google Scholar]
- 48.Sequeira M., Espírito-santo M.D. Checklist da Flora de Portugal. ALFA; Lisboa, Portugal: 2011. [Google Scholar]
- 49.Wilson M. What Juniper Means? [(accessed on 22 December 2021)]. Available online: https://www.restaurantnorman.com/what-juniper-means/
- 50.Živić N., Milošević S., Dekić V., Dekić B., Ristić N., Ristić M., Sretić L. Phytochemical and antioxidant screening of some extracts of Juniperus communis L.and Juniperus oxycedrus L. Czech J. Food Sci. 2019;37:351–358. doi: 10.17221/28/2019-CJFS. [DOI] [Google Scholar]
- 51.Bento C., Gonçalves A.C., Silva B., Silva L.R. Peach (Prunus Persica): Phytochemicals and health benefits. Food Rev. Int. 2020. Ahead-of-print . [DOI]
- 52.Pott D.M., Osorio S., Vallarino J.G. From central to specialized metabolism: An overview of some secondary compounds derived from the primary metabolism for their role in conferring nutritional and organoleptic characteristics to fruit. Front. Plant Sci. 2019;10:835. doi: 10.3389/fpls.2019.00835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mediavilla I., Guillamón E., Ruiz A., Esteban L.S. Essential oils from residual foliage of forest tree and shrub species: Yield and antioxidant capacity. Molecules. 2021;26:3257. doi: 10.3390/molecules26113257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Bento C., Gonçalves A.C., Jesus F., Simões M., Silva L.R. Phenolic compounds: Sources, properties and applications. In: Porter R., Parker N., editors. Bioactive Compounds: Sources, Properties and Applications. Nova Science Publishers, Inc; New York, NY, USA: 2017. pp. 271–299. [Google Scholar]
- 55.Fatima N., Baqri S.S.R., Alsulimani A., Fagoonee S., Slama P., Kesari K.K., Roychoudhury S., Haque S. Phytochemicals from Indian ethnomedicines: Promising prospects for the management of oxidative stress and cancer. Antioxidants. 2021;10:1606. doi: 10.3390/antiox10101606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Rabska M., Robakowski P., Ratajczak E., Żytkowiak R., Iszkuło G., Pers-Kamczyc E. Photochemistry differs between male and female Juniperus communis L. independently of nutritional availability. Trees Struct. Funct. 2021;35:27–42. doi: 10.1007/s00468-020-02004-8. [DOI] [Google Scholar]
- 57.Chiorcea-Paquim A.M., Enache T.A., De Souza Gil E., Oliveira-Brett A.M. Natural phenolic antioxidants electrochemistry: Towards a new food science methodology. Compr. Rev. Food Sci. Food Saf. 2020;19:1680–1726. doi: 10.1111/1541-4337.12566. [DOI] [PubMed] [Google Scholar]
- 58.Singla R.K., Dubey A.K., Garg A., Sharma R.K., Fiorino M., Ameen S.M., Haddad M.A., Al-Hiary M. Natural polyphenols: Chemical classification, definition of classes, subcategories, and structures. J. AOAC Int. 2019;102:1397–1400. doi: 10.5740/jaoacint.19-0133. [DOI] [PubMed] [Google Scholar]
- 59.Gonçalves A.C., Rodrigues M., Santos A.O., Alves G., Silva L.R. Antioxidant status, antidiabetic properties and effects on Caco-2 cells of colored and non-colored enriched extracts of sweet cherry fruits. Nutrients. 2018;10:1688. doi: 10.3390/nu10111688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Olech M., Nowak R., Ivanova D., Tashev A., Boyadzhieva S., Kalotova G., Angelov G., Gawlik-Dziki U. LC-ESI-MS/ MS-MRM profiling of polyphenols and antioxidant activity evaluation of Junipers of different origin. Appl. Sci. 2020;10:8921. doi: 10.3390/app10248921. [DOI] [Google Scholar]
- 61.Orhan N., Orhan I.E., Ergun F. Insights into cholinesterase inhibitory and antioxidant activities of five Juniperus species. Food Chem. Toxicol. 2011;49:2305–2312. doi: 10.1016/j.fct.2011.06.031. [DOI] [PubMed] [Google Scholar]
- 62.Mahmutović I., Dahija S., Bešta-Gajević R., Karalija E. Biological activity of Juniperus communis L. extracts; Proceedings of the 28th International Scientific-Expert Conference of Agriculture and Food Industry; Sarajevo, Bosnia and Herzegovina. 27–29 September 2017. [Google Scholar]
- 63.Brodowska A.J., Smigielski K., Nowak A., Czyzowska A., Otlewska A. The impact of ozone treatment in dynamic bed parameters on changes in biologically active substances of juniper berries. PLoS ONE. 2015;10:e0144855. doi: 10.1371/journal.pone.0144855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Luís Â., Domingues F., Duarte A.P. Bioactive compounds, RP-HPLC analysis of phenolics, and antioxidant activity of some Portuguese shrub species extracts. Nat. Prod. Commun. 2011;6:1863–1872. doi: 10.1177/1934578X1100601219. [DOI] [PubMed] [Google Scholar]
- 65.Ved A., Gupta A., Rawat A. Antioxidant and hepatoprotective potential of phenol-rich fraction of Juniperus communis Linn. leaves. Pharmacogn. Mag. 2017;13:108–113. doi: 10.4103/0973-1296.197648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Orhan N., Hoşbaş S., Orhan D.D., Aslan M., Ergun F. Enzyme inhibitory and radical scavenging effects of some antidiabetic plants of Turkey. Iran. J. Basic Med. Sci. 2014;17:426–432. doi: 10.22038/ijbms.2014.2927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Fejér J., Kron I., Grul’ová D., Eliašová A. Seasonal variability of Juniperus communis L. berry ethanol extracts: 1. In vitro hydroxyl radical scavenging activity. Molecules. 2020;25:4114. doi: 10.3390/molecules25184114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Tang J., Dunshea F.R., Suleria H.A.R. LC-ESI-QTOF/MS characterization of phenolic compounds from medicinal plants (Hops and Juniper Berries) and their antioxidant activity. Foods. 2020;9:7. doi: 10.3390/foods9010007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Harris C.S., Cuerrier A., Lamont E., Haddad P.S., Arnason J.T., Bennett S.A.L., Johns T. Investigating wild berries as a dietary approach to reducing the formation of advanced glycation endproducts: Chemical correlates of in vitro antiglycation activity. Plant Foods Hum. Nutr. 2014;69:71–77. doi: 10.1007/s11130-014-0403-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Miceli N., Trovato A., Dugo P., Cacciol F., Donato P., Marino A., Bellinghieri V., La Barbera Tommaso M., Güvenç A., Taviano M.F. Comparative analysis of flavonoid profile, antioxidant and antimicrobial activity of the berries of Juniperus communis L. var. communis and Juniperus communis L. var. saxatilis Pall. from Turkey. J. Agric. Food Chem. 2009;57:6570–6577. doi: 10.1021/jf9012295. [DOI] [PubMed] [Google Scholar]
- 71.Vasilijević B., Knežević-Vukčević J., Mitić-Ćulafić D., Orčić D., Francišković M., Srdic-Rajic T., Jovanović M., Nikolić B. Chemical characterization, antioxidant, genotoxic and in vitro cytotoxic activity assessment of Juniperus communis var. saxatilis. Food Chem. Toxicol. 2018;112:118–125. doi: 10.1016/j.fct.2017.12.044. [DOI] [PubMed] [Google Scholar]
- 72.Sahin Yaglioglu A., Eser F. Screening of some Juniperus extracts for the phenolic compounds and their antiproliferative activities. S. Afr. J. Bot. 2017;113:29–33. doi: 10.1016/j.sajb.2017.07.005. [DOI] [Google Scholar]
- 73.Gao H.W., Huang X.F., Yang T.P., Chang K.F., Yeh L.W., Hsieh M.C., Weng J.C., Tsai N.M. Juniperus communis suppresses melanoma tumorigenesis by inhibiting tumor growth and inducing apoptosis. Am. J. Chin. Med. 2019;47:1171–1191. doi: 10.1142/S0192415X19500605. [DOI] [PubMed] [Google Scholar]
- 74.Elboughdiri N., Ghernaout D., Kriaa K., Jamoussi B. Enhancing the extraction of phenolic compounds from juniper berries using the box-behnken design. ACS Omega. 2020;5:27990–28000. doi: 10.1021/acsomega.0c03396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Xavier V., Finimundy T.C., Heleno S.A., Amaral J.S., Calhelha R.C., Vaz J., Pires T.C.S.P., Mediavilla I., Esteban L.S., Ferreira I.C.F.R., et al. Chemical and bioactive characterization of the essential oils obtained from three Mediterranean plants. Molecules. 2021;26:7472. doi: 10.3390/molecules26247472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Kılıç Ö., Kocak A. Volatile constituents of Juniperus communis L., Taxus canadensis Marshall. and Tsuga canadensis (L.) Carr. from Canada. J. Agric. Sci. Technol. B. 2014;4:135–140. doi: 10.1021/bk-2001-0794.ch004. [DOI] [Google Scholar]
- 77.Johnson W. Final report on the safety assessment of Juniperus communis extract, Juniperus oxycedrus extract, Juniperus oxycedrus tar, Juniperus phoenicea extract, and Juniperus virginiana extract. Int. J. Toxicol. 2001;20:41–56. doi: 10.1080/10915810160233758. [DOI] [PubMed] [Google Scholar]
- 78.Zheljazkov V.D., Astatkie T., Jeliazkova E.A., Heidel B., Ciampa L. Essential oil content, composition and bioactivity of Juniper species in Wyoming, United States. Nat. Prod. Commun. 2017;12:201–204. doi: 10.1177/1934578X1701200215. [DOI] [PubMed] [Google Scholar]
- 79.Rajcevic N., Dodos T., Novakovic J., Janackovic P., Marin P. Essential oil composition and antioxidant activity of two Juniperus communis L. varieties growing wild in Serbia. Zb. Matice Srp. Prir. Nauke. 2016;131:197–205. doi: 10.2298/ZMSPN1631197R. [DOI] [Google Scholar]
- 80.Gonny M., Cavaleiro C., Salgueiro L., Casanova J. Analysis of Juniperus communis subsp. alpina needle, berry, wood and root oils by combination of GC, GC/MS and 13C-NMR. Flavour Fragr. J. 2006;21:99–106. doi: 10.1002/ffj.1527. [DOI] [Google Scholar]
- 81.Falcão S., Bacém I., Igrejas G., Rodrigues P.J., Vilas-Boas M., Amaral J.S. Chemical composition and antimicrobial activity of hydrodistilled oil from Juniper berries. Ind. Crops Prod. 2018;124:878–884. doi: 10.1016/j.indcrop.2018.08.069. [DOI] [Google Scholar]
- 82.Chatzopoulou P.S., Katsiotis S.T. Headspace analysis of the volatile constituents from Juniperus communis L. “berries” (cones) grown wild in Greece. Flavour Fragr. J. 2006;21:492–496. doi: 10.1002/ffj.1615. [DOI] [Google Scholar]
- 83.Shahmir F., Ahmadi L., Mirza M., Korori S.A.A. Secretory elements of needles and berries of Juniperus communis L. ssp. communis and its volatile constituents. Flavour Fragr. J. 2003;18:425–428. doi: 10.1002/ffj.1243. [DOI] [Google Scholar]
- 84.Cavaleiro C., Pinto E., Gonçalves M.J., Salgueiro L. Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J. Appl. Microbiol. 2006;100:1333–1338. doi: 10.1111/j.1365-2672.2006.02862.x. [DOI] [PubMed] [Google Scholar]
- 85.Cioanca O., Hancianu M., Mihasan M., Hritcu L. Anti-acetylcholinesterase and antioxidant activities of inhaled Juniper oil on amyloid beta (1–42)-induced oxidative stress in the rat hippocampus. Neurochem. Res. 2015;40:952–960. doi: 10.1007/s11064-015-1550-0. [DOI] [PubMed] [Google Scholar]
- 86.Stanić G., Samaržija I., Blažević N. Time-dependent diuretic response in rats treated with Juniper berry preparations. Phyther. Res. 1998;12:494–497. doi: 10.1002/(SICI)1099-1573(199811)12:7<494::AID-PTR340>3.0.CO;2-N. [DOI] [Google Scholar]
- 87.Pramanik K.C., Biswas R., Bandyopadhyay D., Mishra M., Ghost C., Chatterjee T.K. Evaluation of anti-ulcer properties of the leaf extract of Juniperus communis L. in animals. J. Nat. Remedies. 2007;7:207–213. doi: 10.18311/jnr/2007/310. [DOI] [Google Scholar]
- 88.Schneider I., Gibbons S., Bucar F. Inhibitory activity of Juniperus communis on 12(S)-HETE production in human platelets. Planta Med. 2004;70:471–474. doi: 10.1055/s-2004-818980. [DOI] [PubMed] [Google Scholar]
- 89.Filipowicz N., Kamiński M., Kurlenda J., Asztemborska M., Ochocka J.R. Antibacterial and antifungal activity of juniper berry oil and its selected components. Phyther. Res. 2003;17:227–231. doi: 10.1002/ptr.1110. [DOI] [PubMed] [Google Scholar]
- 90.Cabral C., Francisco V., Cavaleiro C., Gonçalves M.J., Cruz M.T., Sales F., Batista M.T., Salgueiro L. Essential oil of Juniperus communis subsp alpina (Suter) Čelak needles: Chemical composition, antifungal activity and cytotoxicity. Phyther. Res. 2012;26:1352–1357. doi: 10.1002/ptr.3730. [DOI] [PubMed] [Google Scholar]
- 91.Angioni A., Barra A., Russo M.T., Coroneo V., Dessí S., Cabras P. Chemical composition of the essential oils of Juniperus from ripe and unripe berries and leaves and their antimicrobial activity. J. Agric. Food Chem. 2003;51:3073–3078. doi: 10.1021/jf026203j. [DOI] [PubMed] [Google Scholar]
- 92.Salamon I., Kryvtsova M., Bucko D., Tarawneh A.H. Chemical characterization and antimicrobial activity of some essential oils after their industrial large-scale distillation. J. Microbiol. Biotechnol. Food Sci. 2019;8:984–988. doi: 10.15414/jmbfs.2019.8.4.984-988. [DOI] [Google Scholar]
- 93.Nikolić B., Vasilijević B., Ćirić A., Mitić-Ćulafić D., Cvetković S., Džamić A., Knežević-Vukčević J. Bioactivity of Juniperus communis essential oil and post-distillation waste: Assessment of selective toxicity against food contaminants. Arch. Biol. Sci. 2019;71:235–244. doi: 10.2298/ABS181217005N. [DOI] [Google Scholar]
- 94.Darwish R.S., Hammoda H.M., Ghareeb D.A., Abdelhamid A.S.A., Bellah El Naggar E.M., Harraz F.M., Shawky E. Efficacy-directed discrimination of the essential oils of three Juniperus species based on their in-vitro antimicrobial and anti-inflammatory activities. J. Ethnopharmacol. 2020;259:112971. doi: 10.1016/j.jep.2020.112971. [DOI] [PubMed] [Google Scholar]
- 95.Ložienė K., Švedienė J., Paškevičius A., Raudonienė V., Sytar O., Kosyan A. Influence of plant origin natural α-pinene with different enantiomeric composition on bacteria, yeasts and fungi. Fitoterapia. 2018;127:20–24. doi: 10.1016/j.fitote.2018.04.013. [DOI] [PubMed] [Google Scholar]
- 96.Klančnik A., Zorko Š., Toplak N., Kovač M., Bucar F., Jeršek B., Smole Možina S. Antiadhesion activity of Juniper (Juniperus communis L.) preparations against Campylobacter jejuni evaluated with PCR-based methods. Phyther. Res. 2018;32:542–550. doi: 10.1002/ptr.6005. [DOI] [PubMed] [Google Scholar]
- 97.Peruč D., Broznić D., Maglica Ž., Marijanović Z., Karleuša L., Gobin I. Biofilm degradation of nontuberculous mycobacteria formed on stainless steel following treatment with immortelle (Helichrysum italicum) and common juniper (Juniperus communis) essential oils. Processes. 2021;9:362. doi: 10.3390/pr9020362. [DOI] [Google Scholar]
- 98.Peruč D., Tićac B., Broznić D., Maglica Ž., Šarolić M., Gobin I. Juniperus communis essential oil limit the biofilm formation of Mycobacterium avium and Mycobacterium intracellulare on polystyrene in a temperature-dependent manner. Int. J. Environ. Health Res. 2020;32:144–154. doi: 10.1080/09603123.2020.1741519. [DOI] [PubMed] [Google Scholar]
- 99.Ferrazzano G.F., Roberto L., Catania M.R., Chiaviello A., De Natale A., Roscetto E., Pinto G., Pollio A., Ingenito A., Palumbo G. Screening and scoring of antimicrobial and biological activities of Italian vulnerary plants against major oral pathogenic bacteria. Evid. Based Complement. Altern. Med. 2013:316280. doi: 10.1155/2013/316280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Kose M., Bayraktar O., Balta A. Antioxidant and Antimicrobial Activities of extracts from some selected Mediterranean plant species. Int. J. New Technol. Res. 2016;2:263506. [Google Scholar]
- 101.Miceli N., Marino A., Köroğlu A., Cacciola F., Dugo P., Mondello L., Taviano M.F. Comparative study of the phenolic profile, antioxidant and antimicrobial activities of leaf extracts of five Juniperus L. (Cupressaceae) taxa growing in Turkey. Nat. Prod. Res. 2020;34:1636–1641. doi: 10.1080/14786419.2018.1523162. [DOI] [PubMed] [Google Scholar]
- 102.Dziedzinski M., Kobus-Cisowska J., Szymanowska D., Stuper-Szablewska K., Baranowska M. Identification of polyphenols from coniferous shoots as natural antioxidants and antimicrobial compounds. Molecules. 2020;25:3527. doi: 10.3390/molecules25153527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Marino A., Bellinghieri V., Nostro A., Miceli N., Taviano M.F., Güvenç A.Ş., Bisignano G. In vitro effect of branch extracts of Juniperus species from Turkey on Staphylococcus aureus biofilm. FEMS Immunol. Med. Microbiol. 2010;59:470–476. doi: 10.1111/j.1574-695X.2010.00705.x. [DOI] [PubMed] [Google Scholar]
- 104.Rolta R., Kumar V., Sourirajan A., Upadhyay N.K., Dev K. Phytocompounds of three medicinal plants (Juniperus communis, Urtica doica and Coleus forskohilii) of North West Himalayas increases the potency of antibacterial and antiffungal antibiotics. Plant Arch. 2020;20:481–489. [Google Scholar]
- 105.Mllhau G., Valentin A., Benoit F., Mallié M., Bastide J.M., Pélissier Y., Bessière J.M. In vitro antimalarial activity of eight essential oils. J. Essent. Oil Res. 1997;9:329–333. doi: 10.1080/10412905.1997.10554252. [DOI] [Google Scholar]
- 106.Van Zyl R.L., Seatlholo S.T., Van Vuuren S.F., Viljoen A.M. The biological activities of 20 nature identical essential oil constituents. J. Essent. Oil Res. 2006;18:129–133. doi: 10.1080/10412905.2006.12067134. [DOI] [Google Scholar]
- 107.Senol F.S., Orhan I.E., Ustun O. In vitro cholinesterase inhibitory and antioxidant effect of selected coniferous tree species. Asian Pac. J. Trop. Med. 2015;8:269–275. doi: 10.1016/S1995-7645(14)60329-1. [DOI] [PubMed] [Google Scholar]
- 108.Gonçalves A.C., Bento C., Nunes A.R., Simões M., Alves G., Silva L.R. Multitarget protection of Pterospartum tridentatum phenolic-rich extracts against a wide range of free radical species, antidiabetic activity and effects on human colon carcinoma (Caco-2) cells. J. Food Sci. 2020;85:4377–4388. doi: 10.1111/1750-3841.15511. [DOI] [PubMed] [Google Scholar]
- 109.Jesus F., Gonçalves A.C., Alves G., Silva L.R. Exploring the phenolic profile, antioxidant, antidiabetic and anti-hemolytic potential of Prunus avium vegetal parts. Food Res. Int. 2018;116:600–610. doi: 10.1016/j.foodres.2018.08.079. [DOI] [PubMed] [Google Scholar]
- 110.Gonçalves A.C., Lahlou R.A., Alves G., Garcia-Viguera C., Moreno D.A., Silva L.R. Potential activity of Abrantes pollen extract: Biochemical and cellular model studies. Foods. 2021;10:2084. doi: 10.3390/foods10112804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Burits M., Asres K., Bucar F. The antioxidant activity of the essential oils of Artemisia afra, Artemisia abyssinica and Juniperus procera. Phyther. Res. 2001;15:103–108. doi: 10.1002/ptr.691. [DOI] [PubMed] [Google Scholar]
- 112.Emami S.A., Abedindo B.F., Hassanzadeh-Khayyat M. Antioxidant activity of the essential oils of different parts of Juniperus excelsa M. Bieb. subsp. excelsa and J. excelsa M. Bieb. subsp. polycarpos (K. Koch) Takhtajan (Cupressaceae) Iran. J. Pharm. Res. 2011;10:799–810. [PMC free article] [PubMed] [Google Scholar]
- 113.Mascolo N., Autore G., Capasso F., Menghini A., Fasulo M.P. Biological screening of Italian medicinal plants for anti-inflammatory activity. Phyther. Res. 1987;1:28–31. doi: 10.1002/ptr.2650010107. [DOI] [Google Scholar]
- 114.Akkol E.K., Güvenç A., Yesilada E. A comparative study on the antinociceptive and anti-inflammatory activities of five Juniperus taxa. J. Ethnopharmacol. 2009;125:330–336. doi: 10.1016/j.jep.2009.05.031. [DOI] [PubMed] [Google Scholar]
- 115.Li X., Yang Y., Li Y., Zhang W.K., Tang H. α-Pinene, linalool, and 1-octanol contribute to the topical anti-in fl ammatory and analgesic activities of frankincense by inhibiting COX-2. J. Ethnopharmacol. 2016;179:22–26. doi: 10.1016/j.jep.2015.12.039. [DOI] [PubMed] [Google Scholar]
- 116.Zhang T.T., Hu T., Jiang J.G., Zhao J.W., Zhu W. Antioxidant and anti-inflammatory effects of polyphenols extracted from Ilex latifolia Thunb. RSC Adv. 2018;8:7134–7141. doi: 10.1039/C7RA13569F. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Zhou J.Y., Tang F.D., Mao G.G., Bian R.L. Effect of α-pinene on nuclear translocation of NF-κB in THP-1 cells. Acta Pharmacol. Sin. 2004;25:480–484. [PubMed] [Google Scholar]
- 118.Limtrakul P., Yodkeeree S., Pitchakarn P., Punfa W. Suppression of inflammatory responses by black rice extract in RAW 264.7 macrophage cells via downregulation of NF-kB and AP-1 signaling pathways. Asian Pac. J. Cancer Prev. 2015;16:4277–4283. doi: 10.7314/APJCP.2015.16.10.4277. [DOI] [PubMed] [Google Scholar]
- 119.Zielińska D.Z., Zieliński H.Z., Giménez-Bastida, Laparra-Llopis J.M., Giménez-Bastida J.A. Caffeic acid modulates processes associated with intestinal inflammation. Nutrients. 2021;13:554. doi: 10.3390/nu13020554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Gonçalves A.C., Nunes A.R., Falcão A., Alves G., Silva L.R. Dietary effects of anthocyanins in human health: A comprehensive review. Pharmaceuticals. 2021;14:690. doi: 10.3390/ph14070690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Kim E.O., Min K.J., Kwon T.K., Um B.H., Moreau R.A., Choi S.W. Anti-inflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in lipopolysaccharide-stimulated Raw 264.7 macrophages. Food Chem. Toxicol. 2012;50:1309–1316. doi: 10.1016/j.fct.2012.02.011. [DOI] [PubMed] [Google Scholar]
- 122.Byung H.K., Sung M.C., Reddy A.M., Yeong S.K., Kyung R.M., Kim Y. Down-regulatory effect of quercitrin gallate on nuclear factor-κB-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7. Biochem. Pharmacol. 2005;69:1577–1583. doi: 10.1016/j.bcp.2005.03.014. [DOI] [PubMed] [Google Scholar]
- 123.Bais S., Abrol N., Prashar Y., Kumari R. Modulatory effect of standardised amentoflavone isolated from Juniperus communis L. agianst Freund’s adjuvant induced arthritis in rats (histopathological and X Ray anaysis) Biomed. Pharmacother. 2017;86:381–392. doi: 10.1016/j.biopha.2016.12.027. [DOI] [PubMed] [Google Scholar]
- 124.Gallagher A.M., Flatt P.R., Duffy G., Abdel-Wahab Y.H.A. The effects of traditional antidiabetic plants on in vitro glucose diffusion. Nutr. Res. 2003;23:413–424. doi: 10.1016/S0271-5317(02)00533-X. [DOI] [Google Scholar]
- 125.Swanston-Flatt S.K., Day C., Bailey C.J., Flat P.R. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia. 1990;33:462–464. doi: 10.1007/BF00405106. [DOI] [PubMed] [Google Scholar]
- 126.Medina F.S., Gamez M.J., Jimenez I., Jimenez J., Osuna J.I., Zarzuelo A. Hypoglycemic activity of Juniper “berries. ” Planta Med. 1994;60:197–200. doi: 10.1055/s-2006-959457. [DOI] [PubMed] [Google Scholar]
- 127.Petlevski R., Hadžija M., Slijepčevič M., Juretič D. Effect of “antidiabetis” herbal preparation on serum glucose and fructosamine in NOD mice. J. Ethnopharmacol. 2001;75:181–184. doi: 10.1016/S0378-8741(01)00177-5. [DOI] [PubMed] [Google Scholar]
- 128.Lee C.C., Hsiao C.Y., Lee S.C., Huang X.F., Chang K.F., Lee M.S., Hsieh M.C., Tsai N.M. Suppression of oral cancer by induction of cell cycle arrest and apoptosis using Juniperus communis extract. Biosci. Rep. 2020;40:BSR20202083. doi: 10.1042/BSR20202083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Ghaly N.S., Mina S.A., Younis N.A.H. In vitro cytotoxic activity and phytochemical analysis of the aerial parts of J. Communis L. cultivated in Egypt. J. Pharm. Sci. Res. 2016;8:128–131. [Google Scholar]
- 130.Van Slambrouck S., Daniels A.L., Hooten C.J., Brock S.L., Jenkins A.R., Ogasawara M.A., Baker J.M., Adkins G., Elias E.M., Agustin V.J., et al. Effects of crude aqueous medicinal plant extracts on growth and invasion of breast cancer cells. Oncol. Rep. 2007;17:1487–1492. doi: 10.3892/or.17.6.1487. [DOI] [PubMed] [Google Scholar]
- 131.Fernandez A., Cock I.E. The therapeutic properties of Juniperus communis L.: Antioxidant capacity, bacterial growth inhibition, anticancer activity and toxicity. Pharmacogn. J. 2016;8:273–280. doi: 10.5530/pj.2016.3.17. [DOI] [Google Scholar]
- 132.Huang N.C., Huang R.L., Huang X.F., Chang K.F., Lee C.J., Hsiao C.Y., Lee S.C., Tsai N.M. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo. Biosci. Rep. 2021;41:BSR20211143. doi: 10.1042/BSR20211143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Lai W.L., Lee S.C., Chang K.F., Huang X.F., Li C.Y., Lee C.J., Wu C.Y., Hsu H.J., Tsai N.M. Juniperus communis extract induces cell cycle arrest and apoptosis of colorectal adenocarcinoma in vitro and in vivo. Braz. J. Med. Biol. Res. 2021;54:1–11. doi: 10.1590/1414-431x2020e10891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Elshafie H.S., Caputo L., De Martino L., Gruľová D., Zheljazkov V.Z., De Feo V., Camele I. Biological investigations of essential oils extracted from three Juniperus species and evaluation of their antimicrobial, antioxidant and cytotoxic activities. J. Appl. Microbiol. 2020;129:1261–1271. doi: 10.1111/jam.14723. [DOI] [PubMed] [Google Scholar]
- 135.Tsai W.C., Tsai N.M., Chang K.F., Wang J.C. Juniperus communis extract exerts antitumor effects in human glioblastomas through blood-brain barrier. Cell. Physiol. Biochem. 2018;49:2443–2462. doi: 10.1159/000493842. [DOI] [PubMed] [Google Scholar]
- 136.Cioanca O., Mircea C., Trifan A., Aprotosoaie A.C., Hritcu L., Hǎncianu M. Improvement of amyloid-β-induced memory deficits by Juniperus communis L. volatile oil in a rat model of Alzheimer’s disease. Farmacia. 2014;62:514–520. [Google Scholar]
- 137.Jegal J., Park S.A., Chung K.W., Chung H.Y., Lee J., Jeong E.J., Kim K.H., Yang M.H. Tyrosinase inhibitory flavonoid from Juniperus communis fruits. Biosci. Biotechnol. Biochem. 2016;80:2311–2317. doi: 10.1080/09168451.2016.1217146. [DOI] [PubMed] [Google Scholar]
- 138.Barzegarnejad A., Azadbakht M., Emadian O., Ahmadi M. Effect of some fractions of the extract of Juniperus communis fruit on solving kidney stones in vitro. J. Maz. Univ. Med. Sci. 2013;23:145–152. [Google Scholar]
- 139.Sturza A., Pleşa C., Ordodi V., Noveanu L., Mirica N., Fira-Mladinescu O., Lupea A.X., Muntean D. Vascular responses of Juniperus communis aerosols in aortic rings isolated from rats subjected to passive smoking. Ann. Rom. Soc. Cell Biol. 2011;16:178–181. [Google Scholar]
- 140.Pleşa C., Ordodi V.L., Noveanu L., Vasile L., Ardelean A., Lupea A.X. Effects of Juniperus communis aerosols on trachea and lung from rat subjected to passive smoking. Stud. Univ. Vasile Goldis Ser. Stiint. Vietii Life Sci. Ser. 2011;21:319–328. [Google Scholar]
- 141.Newman D.J., Cragg G.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770–803. doi: 10.1021/acs.jnatprod.9b01285. [DOI] [PubMed] [Google Scholar]
- 142.Lantto T.A., Laakso I., Dorman H.J.D., Mauriala T., Hiltunen R., Kõks S., Raasmaja A. Cellular stress and p53-associated apoptosis by Juniperus communis L. berry extract treatment in the human SH-SY5Y neuroblastoma cells. Int. J. Mol. Sci. 2016;17:1113. doi: 10.3390/ijms17071113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.De Marino S., Cattaneo F., Festa C., Zollo F., Iaccio A., Ammendola R., Incollingo F., Iorizzi M. Imbricatolic acid from Juniperus communis L. prevents cell cycle progression in CaLu-6 cells. Planta Med. 2011;77:1822–1828. doi: 10.1055/s-0030-1271104. [DOI] [PubMed] [Google Scholar]
- 144.Benzina S., Harquail J., Jean S., Beauregard A.-P., Colquhoun C., Carroll M., Bos A., Gray C., Robichaud G. Deoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells. Anticancer Agents Med. Chem. 2014;15:79–88. doi: 10.2174/1871520614666140608150448. [DOI] [PubMed] [Google Scholar]
- 145.Singh H., Prakash A., Kalia A.N., Majeed A.B.A. Synergistic hepatoprotective potential of ethanolic extract of Solanum xanthocarpum and Juniperus communis against paracetamol and azithromycin induced liver injury in rats. J. Tradit. Complement. Med. 2016;6:370–376. doi: 10.1016/j.jtcme.2015.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Tisserand R., Young R. In: Essential oil Safety: A Guide for Health Care Professionals. 2nd ed. Tisserand R., Young R., editors. Elsevier Health Sciences; Amsterdam, The Netherlands: 2013. [Google Scholar]
- 147.Pathak S., Tewari R.K., Prakash A.O. Hormonal properties of ethanolic extract of Juniperus communis Linn. Anc. Sci. Life. 1990;10:106–113. [PMC free article] [PubMed] [Google Scholar]
- 148.Agrawal O.P., Bharadwaj S., Mathur R. Antifertility effects of fruits of Juniperus communis. J. Med. Plant Res. 1980:98–101. doi: 10.1055/s-2008-1075011. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data are reported in the manuscript.